| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 6.19e-07 | 14 | 257 | 5 | GO:0005130 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 5.84e-06 | 21 | 257 | 5 | GO:0042975 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 9.46e-06 | 23 | 257 | 5 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 3.13e-05 | 29 | 257 | 5 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 3.13e-05 | 29 | 257 | 5 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 6.97e-05 | 34 | 257 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | glycolipid binding | 4.08e-04 | 49 | 257 | 5 | GO:0051861 | |
| GeneOntologyMolecularFunction | natriuretic peptide receptor activity | 4.91e-04 | 3 | 257 | 2 | GO:0016941 | |
| GeneOntologyMolecularFunction | sodium channel activity | 5.39e-04 | 52 | 257 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 6.99e-04 | 55 | 257 | 5 | GO:0061733 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 7.06e-04 | 149 | 257 | 8 | GO:1990782 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 1.13e-07 | 87 | 253 | 10 | GO:0001974 | |
| GeneOntologyBiologicalProcess | intracellular transport | SMG1 GRIPAP1 SEC24A SYTL2 PEX1 KIF4A FAM91A1 BCR NUP54 EHD4 BRCA1 GLE1 GLI3 RAB3GAP2 BSN NUP160 RIC1 FLNA TRAPPC11 RELCH RANBP2 COPG1 APBA1 TMED7 POM121L2 VPS54 MED1 SAR1A LEP PIKFYVE LIPA MAP1LC3C NETO1 VPS35 STAU2 TENM1 LRP2 IPO13 LRBA GRAMD1C HTT PINK1 | 3.78e-07 | 1496 | 253 | 42 | GO:0046907 |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 4.23e-07 | 39 | 253 | 7 | GO:0045717 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 4.68e-07 | 25 | 253 | 6 | GO:0035726 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 4.88e-07 | 14 | 253 | 5 | GO:0070348 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 6.77e-07 | 60 | 253 | 8 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 7.25e-07 | 15 | 253 | 5 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 7.25e-07 | 15 | 253 | 5 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 7.25e-07 | 15 | 253 | 5 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 7.25e-07 | 15 | 253 | 5 | GO:1903387 | |
| GeneOntologyBiologicalProcess | microtubule-based process | TEKT3 CFAP251 CATSPERE STAG1 PEX1 KIF4A CUL9 TOGARAM1 NCKAP5 CLASP2 ATAT1 LRRC43 DNALI1 BRCA1 MID1 BSN DNM2 FLNA COPG1 APBA1 RFX3 NCOR1 C2CD3 AKAP9 NETO1 SBDS STAU2 MACF1 CDK5RAP2 CCN2 CEP152 GPSM1 HTT | 8.21e-07 | 1058 | 253 | 33 | GO:0007017 |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.04e-06 | 16 | 253 | 5 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.46e-06 | 17 | 253 | 5 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.46e-06 | 17 | 253 | 5 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.46e-06 | 17 | 253 | 5 | GO:0038158 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | GRIPAP1 SEC24A SYTL2 PEX1 FAM91A1 BCR NUP54 BRCA1 GLI3 RAB3GAP2 RIC1 FLNA RANBP2 COPG1 APBA1 TMED7 POM121L2 VPS54 MED1 SAR1A LEP MAP1LC3C NETO1 VPS35 TENM1 IPO13 | 1.57e-06 | 740 | 253 | 26 | GO:0006886 |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.01e-06 | 18 | 253 | 5 | GO:1903385 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 2.13e-06 | 49 | 253 | 7 | GO:0072576 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 2.23e-06 | 32 | 253 | 6 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 2.23e-06 | 32 | 253 | 6 | GO:0060312 | |
| GeneOntologyBiologicalProcess | growth | RAPH1 PSG1 PSG2 PSG4 PSG9 PSG11 SPTBN2 CLASP2 MEF2C KMT2C ADRB3 BRCA1 GLI3 PRMT2 C3 FGFR3 FGFR2 UNC79 PLXNA1 DNM2 NPR1 NPR2 APBA1 VPS54 MED1 PRDM4 LEP NCOR1 EYS TENM4 TIAM1 SBDS TNN EIF4G1 MACF1 | 3.27e-06 | 1235 | 253 | 35 | GO:0040007 |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 3.32e-06 | 98 | 253 | 9 | GO:0061045 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 3.56e-06 | 20 | 253 | 5 | GO:2000346 | |
| GeneOntologyBiologicalProcess | central nervous system development | FOXR1 SPTBN2 MDGA2 ATAT1 ARID1A BCR FZD6 BPTF GRK2 GLI3 SCN2A EIF2B3 SCN5A NSUN5P2 SMG9 C3 FGFR3 FGFR2 PLXNA1 FLNA DHX37 GRIK1 VPS54 GRIN2B NCSTN MED1 LEP NCOR1 C2CD3 TENM4 LRP2 CDK5RAP2 HTT EPHA5 | 4.38e-06 | 1197 | 253 | 34 | GO:0007417 |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 4.63e-06 | 21 | 253 | 5 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 4.63e-06 | 21 | 253 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 4.63e-06 | 21 | 253 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | behavior | SCN11A PSG1 TRPM7 PSG2 PSG4 PSG9 PSG11 SPTBN2 MDGA2 MEF2C PCDH17 ADRB3 GLI3 SCN2A UNC79 APBA1 GRIK1 VPS54 GRIN2B NCSTN CREBBP LEP NCOR1 NETO1 VPS35 EIF4G1 GAA HTT | 5.21e-06 | 891 | 253 | 28 | GO:0007610 |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 5.93e-06 | 22 | 253 | 5 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 6.38e-06 | 38 | 253 | 6 | GO:2000345 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 7.50e-06 | 23 | 253 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 7.50e-06 | 23 | 253 | 5 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 9.38e-06 | 24 | 253 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 9.38e-06 | 24 | 253 | 5 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 9.38e-06 | 24 | 253 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | organelle assembly | TEKT3 STAG1 RC3H1 SPTBN2 KIF4A TOGARAM1 CLASP2 NEB ATAT1 LRRC43 MEF2C DNALI1 EHD4 BRCA1 TBC1D1 RAB3GAP2 DNM2 FLNA DHX37 RFX3 PIKFYVE NCOR1 PTPDC1 C2CD3 CELSR3 MAP1LC3C SBDS CDK5RAP2 CEP152 LRBA HTT PINK1 | 1.05e-05 | 1138 | 253 | 32 | GO:0070925 |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.16e-05 | 25 | 253 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.16e-05 | 42 | 253 | 6 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.62e-05 | 66 | 253 | 7 | GO:0010543 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 1.62e-05 | 91 | 253 | 8 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.73e-05 | 27 | 253 | 5 | GO:0070344 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 1.73e-05 | 27 | 253 | 5 | GO:0035235 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | SMG1 SPTBN2 MAP3K20 CUL9 TOGARAM1 CLASP2 NEB ATAT1 ARID1A MEF2C CRACD BRCA1 ANAPC1 TBC1D1 RAB3GAP2 MID1 FGFR3 FGFR2 DNM2 FLNA NPR2 CARMIL1 SAR1A CIT MFN1 PIKFYVE AKAP9 VPS35 STAU2 TENM1 CDK5RAP2 CCN2 HTT PINK1 EPHA5 | 1.96e-05 | 1342 | 253 | 35 | GO:0033043 |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | KDM5D ARID1A MEF2C BRCA1 SCNN1G PRMT2 ALPL DNM2 FLNA NPR2 VPS54 NCSTN MED1 PIAS2 LEP NCOR1 AKAP9 VPS35 GRAMD1C HTT EPHA5 | 1.98e-05 | 605 | 253 | 21 | GO:0071407 |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.99e-05 | 46 | 253 | 6 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.99e-05 | 46 | 253 | 6 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 2.08e-05 | 28 | 253 | 5 | GO:0034111 | |
| GeneOntologyBiologicalProcess | brain development | FOXR1 SPTBN2 ATAT1 ARID1A BCR FZD6 BPTF GLI3 SCN2A SCN5A NSUN5P2 SMG9 FGFR3 FGFR2 PLXNA1 FLNA DHX37 GRIN2B NCSTN MED1 NCOR1 C2CD3 LRP2 CDK5RAP2 HTT EPHA5 | 2.20e-05 | 859 | 253 | 26 | GO:0007420 |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 2.26e-05 | 47 | 253 | 6 | GO:0034104 | |
| GeneOntologyBiologicalProcess | tissue remodeling | PSG1 PSG2 PSG4 PSG9 PSG11 BCR MEF2C FGFR3 FLNA NPR2 LEP CRB1 LIPA | 2.28e-05 | 262 | 253 | 13 | GO:0048771 |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 2.49e-05 | 29 | 253 | 5 | GO:2001212 | |
| GeneOntologyBiologicalProcess | head development | FOXR1 SPTBN2 ATAT1 ARID1A BCR FZD6 BPTF GLI3 SCN2A SCN5A NSUN5P2 SMG9 FGFR3 FGFR2 PLXNA1 FLNA DHX37 GRIN2B NCSTN MED1 CREBBP NCOR1 C2CD3 LRP2 CDK5RAP2 HTT EPHA5 | 2.56e-05 | 919 | 253 | 27 | GO:0060322 |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 2.58e-05 | 126 | 253 | 9 | GO:1903035 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 2.62e-05 | 71 | 253 | 7 | GO:0043114 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | PSG1 PSG2 PSG4 PSG9 PSG11 RC3H1 CD109 CLASP2 NEB ARID1A MEF2C FZD6 BRCA1 GLI3 C3 FGFR2 PLXNA1 DOCK1 DOCK2 FLNA NPR1 NPR2 PCDHA12 MED1 LEP CRB1 PIKFYVE TENM4 RTL1 TNN DCHS1 LRP2 MACF1 CCN2 USPL1 HTT EPHA5 | 2.90e-05 | 1483 | 253 | 37 | GO:0048646 |
| GeneOntologyBiologicalProcess | blood vessel development | SCN11A PSG1 PSG2 PSG4 PSG9 PSG11 ARID1A MEF2C BRCA1 GLI3 C3 FGFR2 DNM2 FLNA NPR1 NPR2 PCDHA12 MED1 LEP LIPA RTL1 TNN NPRL3 LRP2 CCN2 GAA EPHA5 | 3.09e-05 | 929 | 253 | 27 | GO:0001568 |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 3.14e-05 | 73 | 253 | 7 | GO:0042304 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PSG1 PSG2 PSG4 PSG9 PSG11 FXYD5 MDGA2 PCDH17 PCDHA12 CRB1 TENM4 CELSR3 TENM1 DCHS1 | 3.49e-05 | 313 | 253 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 3.49e-05 | 31 | 253 | 5 | GO:0010544 | |
| GeneOntologyBiologicalProcess | NMDA selective glutamate receptor signaling pathway | 3.55e-05 | 6 | 253 | 3 | GO:0098989 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 4.02e-05 | 166 | 253 | 10 | GO:0061041 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 4.10e-05 | 32 | 253 | 5 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 4.55e-05 | 53 | 253 | 6 | GO:0034110 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 4.78e-05 | 33 | 253 | 5 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 4.78e-05 | 33 | 253 | 5 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 5.55e-05 | 34 | 253 | 5 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 5.55e-05 | 34 | 253 | 5 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 5.70e-05 | 80 | 253 | 7 | GO:0046850 | |
| GeneOntologyBiologicalProcess | developmental growth | RAPH1 SPTBN2 CLASP2 MEF2C KMT2C ADRB3 GLI3 PRMT2 C3 FGFR3 FGFR2 UNC79 PLXNA1 DNM2 NPR2 APBA1 VPS54 MED1 LEP NCOR1 EYS TENM4 TIAM1 SBDS TNN MACF1 | 5.89e-05 | 911 | 253 | 26 | GO:0048589 |
| GeneOntologyBiologicalProcess | cell proliferation in bone marrow | 5.91e-05 | 18 | 253 | 4 | GO:0071838 | |
| GeneOntologyBiologicalProcess | vacuole organization | ATP10B RAB3GAP2 NPR2 VPS54 TASL PIKFYVE LIPA MAP1LC3C VPS35 LRBA GAA PINK1 | 6.24e-05 | 249 | 253 | 12 | GO:0007033 |
| GeneOntologyBiologicalProcess | vasculature development | SCN11A PSG1 PSG2 PSG4 PSG9 PSG11 ARID1A MEF2C BRCA1 GLI3 C3 FGFR2 DNM2 FLNA NPR1 NPR2 PCDHA12 MED1 LEP LIPA RTL1 TNN NPRL3 LRP2 CCN2 GAA EPHA5 | 6.33e-05 | 969 | 253 | 27 | GO:0001944 |
| GeneOntologyBiologicalProcess | insulin metabolic process | 6.41e-05 | 35 | 253 | 5 | GO:1901142 | |
| GeneOntologyBiologicalProcess | cell junction organization | GRIPAP1 PSG1 PSG2 PSG4 PSG9 PSG11 SPTBN2 MDGA2 CLASP2 BCR MEF2C PCDH17 C3 FGFR2 BSN DOCK1 FLNA PPFIA4 GRIN2B MFN1 TENM4 TIAM1 VPS35 STAU2 EIF4G1 MACF1 EPHA5 | 6.91e-05 | 974 | 253 | 27 | GO:0034330 |
| GeneOntologyBiologicalProcess | gland morphogenesis | 7.24e-05 | 178 | 253 | 10 | GO:0022612 | |
| GeneOntologyBiologicalProcess | energy homeostasis | 7.36e-05 | 144 | 253 | 9 | GO:0097009 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 7.76e-05 | 145 | 253 | 9 | GO:0045833 | |
| GeneOntologyBiologicalProcess | regulation of response to wounding | PSG1 PSG2 PSG4 PSG9 PSG11 CD109 CLASP2 FLNA MUC16 MMRN1 ANO6 | 8.04e-05 | 217 | 253 | 11 | GO:1903034 |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 8.39e-05 | 59 | 253 | 6 | GO:0007215 | |
| GeneOntologyBiologicalProcess | circulatory system development | SCN11A PSG1 PSG2 PSG4 PSG9 PSG11 NEB ARID1A MEF2C GRK2 BRCA1 GLI3 SCN5A SMG9 C3 FGFR2 DNM2 ATF7 FLNA NPR1 NPR2 PCDHA12 MED1 LEP LIPA C2CD3 TENM4 RTL1 TNN DCHS1 NPRL3 LRP2 CCN2 GAA EPHA5 | 8.47e-05 | 1442 | 253 | 35 | GO:0072359 |
| GeneOntologyBiologicalProcess | bone development | MEF2C GLI3 FGFR3 FGFR2 ALPL NPR2 LEP LIPA ANO6 SBDS TNN DCHS1 | 1.09e-04 | 264 | 253 | 12 | GO:0060348 |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell proliferation | PSG1 PSG2 PSG4 PSG9 PSG11 CD109 MEF2C FGFR3 FGFR2 MUC16 MED1 | 1.15e-04 | 226 | 253 | 11 | GO:0050680 |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1.22e-04 | 63 | 253 | 6 | GO:0007157 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 1.24e-04 | 40 | 253 | 5 | GO:1990806 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.24e-04 | 40 | 253 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | response to alcohol | SCN11A BRCA1 SCNN1G FGFR2 GRIN3A UNC79 GRIN2B LEP LIPA EIF4G1 GRAMD1C GABBR1 EPHA5 | 1.35e-04 | 312 | 253 | 13 | GO:0097305 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.39e-04 | 41 | 253 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | blood circulation | SCN11A PSG1 PSG2 PSG4 PSG9 PSG11 BCR ADRB3 GRK2 SCN2A SCN5A SCNN1G FLNA NPR1 NPR2 LEP AKAP9 CCN2 SLC4A5 GAA | 1.56e-04 | 648 | 253 | 20 | GO:0008015 |
| GeneOntologyBiologicalProcess | organelle localization | SCN11A SYTL2 PEX1 FAM91A1 CLASP2 PCDH17 FGFR2 BSN CLUH DNM2 TRAPPC11 COPG1 SAR1A MILR1 MFN1 AKAP9 CDK5RAP2 GPSM1 SLC4A5 HTT PINK1 | 1.67e-04 | 703 | 253 | 21 | GO:0051640 |
| GeneOntologyBiologicalProcess | platelet aggregation | 1.70e-04 | 95 | 253 | 7 | GO:0070527 | |
| GeneOntologyBiologicalProcess | feeding behavior | 1.81e-04 | 162 | 253 | 9 | GO:0007631 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 1.85e-04 | 128 | 253 | 8 | GO:0034103 | |
| GeneOntologyBiologicalProcess | regulation of cell development | PSG1 PSG2 PSG4 TCP11X2 PSG9 PSG11 RC3H1 ARID1A MEF2C TESPA1 BNC1 GLI3 CD101 FGFR3 PLXNA1 NPR2 MED1 PIAS2 RFX3 CIT LEP MFN1 TENM4 TIAM1 STAU2 LRP2 MACF1 SPEN | 1.97e-04 | 1095 | 253 | 28 | GO:0060284 |
| GeneOntologyBiologicalProcess | response to hormone | SCN11A PSG1 PSG2 PSG4 PSG9 PSG11 KDM5D ARID1A MEF2C STAT4 GRK2 BRCA1 EIF2B3 SCNN1G PRMT2 ALPL NPR2 GRB10 SCLY VPS54 MED1 PIAS2 LEP SLC22A12 NCOR1 LRP2 EPHA5 | 2.08e-04 | 1042 | 253 | 27 | GO:0009725 |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 2.18e-04 | 45 | 253 | 5 | GO:0048521 | |
| GeneOntologyBiologicalProcess | pinocytosis | 2.28e-04 | 25 | 253 | 4 | GO:0006907 | |
| GeneOntologyBiologicalProcess | secretion | SCN11A SEC24A SPTBN2 SYTL2 CLASP2 BCR MEF2C GRK2 TBC1D1 RIC1 TRAPPC11 NPR1 COPG1 APBA1 GRIK1 GRIN2B MED1 RFX3 LEP MILR1 PIKFYVE MIDN TIAM1 VPS35 CCN2 SLC4A5 GABBR1 HTT PINK1 EPHA5 | 2.30e-04 | 1221 | 253 | 30 | GO:0046903 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | STAG1 KIF4A CUL9 TOGARAM1 NCKAP5 CLASP2 ATAT1 LRRC43 BRCA1 MID1 DNM2 FLNA NCOR1 C2CD3 AKAP9 SBDS CDK5RAP2 CCN2 CEP152 GPSM1 HTT | 2.31e-04 | 720 | 253 | 21 | GO:0000226 |
| GeneOntologyBiologicalProcess | endocytosis | PSG1 PSG2 MYO7B PSG4 PSG9 PSG11 BCR EHD4 ADRB3 GRK2 CLCN5 C3 DNM2 DOCK1 DOCK2 CARMIL1 LEP PIKFYVE LIPA CD22 ELMO2 ANO6 LRP2 | 2.32e-04 | 827 | 253 | 23 | GO:0006897 |
| GeneOntologyBiologicalProcess | hemopoiesis | PSG1 PSG2 PSG4 PSG9 PSG11 RC3H1 CD109 ARID1A BCR MEF2C TESPA1 STAT4 TXK GLI3 CD101 FGFR3 FGFR2 DOCK1 DOCK2 ATF7 FLNA VPS54 MED1 LEP NCOR1 LIPA SBDS TNFSF8 PRG4 PINK1 | 2.36e-04 | 1223 | 253 | 30 | GO:0030097 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.08e-06 | 16 | 258 | 5 | GO:0070021 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SCN11A GRIPAP1 INPP4A SPTBN2 MDGA2 CLASP2 BCR PCDH17 GRK2 SCN2A GRIN3A BSN PLXNA1 DNM2 DOCK1 FLNA PPFIA4 APBA1 GRIK1 GRIN2B TENM4 AKAP9 CELSR3 TIAM1 NETO1 VPS35 GABBR1 HTT | 1.13e-06 | 817 | 258 | 28 | GO:0098978 |
| GeneOntologyCellularComponent | sodium channel complex | 2.57e-05 | 29 | 258 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | guanyl-nucleotide exchange factor complex | 1.98e-04 | 24 | 258 | 4 | GO:0032045 | |
| GeneOntologyCellularComponent | axonal growth cone | 2.25e-04 | 45 | 258 | 5 | GO:0044295 | |
| GeneOntologyCellularComponent | axon | SCN11A GRIPAP1 TRPM7 KIF4A CLASP2 ATAT1 BCR GRK2 SCN2A SCN5A BSN DNM2 FLNA GRIK1 GRIN2B TIAM1 NETO1 TNN STAU2 LRP2 GABBR1 HTT PINK1 EPHA5 | 2.99e-04 | 891 | 258 | 24 | GO:0030424 |
| GeneOntologyCellularComponent | receptor complex | PSG1 PSG2 PSG4 PSG9 PSG11 ADRB3 FGFR3 FGFR2 GRIN3A PLXNA1 FLNA NPR1 GRIK1 GRIN2B LRP2 IL3RA GABBR1 EPHA5 | 3.44e-04 | 581 | 258 | 18 | GO:0043235 |
| GeneOntologyCellularComponent | synaptic membrane | SCN11A GRIPAP1 PCDH17 SCN2A GRIN3A BSN DNM2 APBA1 GRIK1 GRIN2B NCSTN AKAP9 CELSR3 TIAM1 NETO1 ANO6 GABBR1 HTT | 3.58e-04 | 583 | 258 | 18 | GO:0097060 |
| GeneOntologyCellularComponent | pericentriolar material | 3.68e-04 | 28 | 258 | 4 | GO:0000242 | |
| GeneOntologyCellularComponent | apical part of cell | ATP6V1C1 PSG1 PSG2 MYO7B PSG4 PSG9 PSG11 SPTBN2 FZD6 GRK2 CLCN5 SCNN1G TMEM114 SLC22A12 CRB1 DCHS1 LRP2 SLC4A5 | 4.30e-04 | 592 | 258 | 18 | GO:0045177 |
| GeneOntologyCellularComponent | cell surface | PSG1 PSG2 PSG4 PSG9 PSG11 CD109 FZD6 SCN5A SCNN1G C3 FGFR3 FGFR2 BSN IGSF3 ALPP ENOX1 PPFIA4 MUC16 GRIN2B FCRL6 MILR1 CD22 ANO6 TNN LRP2 IL3RA EPHA5 | 6.26e-04 | 1111 | 258 | 27 | GO:0009986 |
| GeneOntologyCellularComponent | lateral plasma membrane | 8.74e-04 | 90 | 258 | 6 | GO:0016328 | |
| GeneOntologyCellularComponent | COPII vesicle coat | 9.24e-04 | 16 | 258 | 3 | GO:0030127 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.11e-03 | 17 | 258 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | FOXR1 PDE9A GGN SPTBN2 EHD4 BPTF SCN5A FGFR3 DNM2 FLNA RANBP2 APBA1 VPS54 PIKFYVE NCOR1 EIF4A2 VPS35 TENM1 CDK5RAP2 CCN2 HTT PINK1 EPHA5 | 1.34e-03 | 934 | 258 | 23 | GO:0048471 |
| GeneOntologyCellularComponent | epsilon DNA polymerase complex | 1.48e-03 | 5 | 258 | 2 | GO:0008622 | |
| GeneOntologyCellularComponent | postsynaptic density | INPP4A BCR GRK2 GRIN3A BSN DNM2 GRIK1 GRIN2B AKAP9 CELSR3 TIAM1 NETO1 VPS35 MACF1 | 1.52e-03 | 451 | 258 | 14 | GO:0014069 |
| GeneOntologyCellularComponent | presynapse | SCN11A ATP6V1C1 GRIPAP1 TRPM7 SPTBN2 PCDH17 GRK2 CLCN5 SCN2A GRIN3A BSN DNM2 PPFIA4 APBA1 GRIK1 GRIN2B NCSTN CELSR3 TNN VPS35 GABBR1 HTT | 1.53e-03 | 886 | 258 | 22 | GO:0098793 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | TEKT3 ATP6V1C1 GRIPAP1 TRPM7 INPP4A SEC24A CD109 ATP10B DCST1 EHD4 FZD6 SERPINB10 CLCN5 RMC1 BSN DNM2 COPG1 UBR4 TMED7 GRIN2B NCSTN TASL SAR1A PIKFYVE ANO6 VPS35 LRP2 GAA HTT | 1.62e-03 | 1307 | 258 | 29 | GO:0030659 |
| GeneOntologyCellularComponent | cytoplasmic region | TEKT3 CFAP251 KIF4A TOGARAM1 CLASP2 LRRC43 DNALI1 GLI3 BSN NETO1 STAU2 HTT | 1.81e-03 | 360 | 258 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | postsynapse | GRIPAP1 INPP4A SPTBN2 BCR MEF2C PCDH17 GRK2 GRIN3A BSN DNM2 DOCK1 FLNA APBA1 GRIK1 GRIN2B AKAP9 CELSR3 TIAM1 NETO1 VPS35 EIF4G1 MACF1 GABBR1 HTT | 1.88e-03 | 1018 | 258 | 24 | GO:0098794 |
| GeneOntologyCellularComponent | vesicle membrane | TEKT3 ATP6V1C1 GRIPAP1 TRPM7 INPP4A SEC24A CD109 ATP10B DCST1 EHD4 FZD6 SERPINB10 CLCN5 RMC1 BSN DNM2 COPG1 UBR4 TMED7 GRIN2B NCSTN TASL SAR1A PIKFYVE ANO6 VPS35 LRP2 GAA HTT | 1.99e-03 | 1325 | 258 | 29 | GO:0012506 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | TEKT3 CFAP251 KIF4A TOGARAM1 LRRC43 DNALI1 GLI3 BSN NETO1 STAU2 HTT | 2.04e-03 | 317 | 258 | 11 | GO:0032838 |
| GeneOntologyCellularComponent | transport vesicle | ATP6V1C1 TRPM7 SEC24A SPTBN2 SYTL2 CLCN5 FGFR3 BSN COPG1 APBA1 TMED7 GRIN2B NCSTN SAR1A GABBR1 | 2.09e-03 | 519 | 258 | 15 | GO:0030133 |
| GeneOntologyCellularComponent | external side of plasma membrane | PSG1 PSG2 PSG4 PSG9 PSG11 SCNN1G ALPP ENOX1 MUC16 FCRL6 MILR1 CD22 LRP2 IL3RA EPHA5 | 2.09e-03 | 519 | 258 | 15 | GO:0009897 |
| GeneOntologyCellularComponent | excitatory synapse | 2.13e-03 | 107 | 258 | 6 | GO:0060076 | |
| GeneOntologyCellularComponent | presynaptic membrane | SCN11A GRIPAP1 PCDH17 SCN2A APBA1 GRIK1 GRIN2B NCSTN CELSR3 GABBR1 | 2.42e-03 | 277 | 258 | 10 | GO:0042734 |
| GeneOntologyCellularComponent | asymmetric synapse | INPP4A BCR GRK2 GRIN3A BSN DNM2 GRIK1 GRIN2B AKAP9 CELSR3 TIAM1 NETO1 VPS35 MACF1 | 2.54e-03 | 477 | 258 | 14 | GO:0032279 |
| HumanPheno | Wide anterior fontanel | 6.18e-06 | 99 | 108 | 11 | HP:0000260 | |
| HumanPheno | Natal tooth | 1.16e-05 | 38 | 108 | 7 | HP:0000695 | |
| HumanPheno | Large fontanelles | PEX1 NEB GLI3 MID1 SMG9 FGFR3 FGFR2 ALPL FLNA CREBBP RTL1 ASXL3 DCHS1 LRP2 | 1.68e-05 | 176 | 108 | 14 | HP:0000239 |
| HumanPheno | Abnormal anterior fontanelle morphology | PEX1 GLI3 MID1 SMG9 FGFR3 FGFR2 FLNA GRB10 CREBBP RTL1 DCHS1 LRP2 | 2.52e-05 | 136 | 108 | 12 | HP:0000236 |
| HumanPheno | Abnormal fontanelle morphology | PEX1 NEB GLI3 MID1 SMG9 FGFR3 FGFR2 ALPL FLNA GRB10 CREBBP RTL1 ASXL3 DCHS1 LRP2 | 3.16e-05 | 211 | 108 | 15 | HP:0011328 |
| HumanPheno | Advanced eruption of teeth | 4.29e-05 | 46 | 108 | 7 | HP:0006288 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 3.23e-06 | 28 | 212 | 6 | MP:0020950 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 4.08e-06 | 17 | 212 | 5 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 1.28e-05 | 21 | 212 | 5 | MP:0031415 | |
| MousePheno | decreased muscle cell glucose uptake | 2.44e-05 | 39 | 212 | 6 | MP:0030022 | |
| MousePheno | decreased fatty acid oxidation | 2.57e-05 | 24 | 212 | 5 | MP:0014172 | |
| MousePheno | polyphagia | 2.79e-05 | 80 | 212 | 8 | MP:0001433 | |
| MousePheno | abnormal intestine morphology | RAPH1 PSG1 PSG2 PSG4 PSG9 PSG11 RC3H1 BCR BRCA1 GLI3 C3 FGFR2 ALPL IGSF3 POLE MSH3 LEP ARAF STPG4 LIPA CELSR3 DCHS1 | 2.92e-05 | 546 | 212 | 22 | MP:0000477 |
| MousePheno | increased abdominal fat pad weight | 4.71e-05 | 27 | 212 | 5 | MP:0009286 | |
| MousePheno | abnormal muscle morphology | STAG1 PSG1 PSG2 PSG4 PSG9 PSG11 MDGA2 NEB ARID1A MEF2C GRK2 SCN5A SMG9 FGFR2 ALPL IGSF3 DNM2 DOCK1 NPR1 NPR2 GRB10 VPS54 MED1 CREBBP LEP ARAF KLHL31 PIKFYVE ELMO2 ASXL3 NPRL3 LRP2 GAA PCOLCE | 5.73e-05 | 1106 | 212 | 34 | MP:0002108 |
| MousePheno | abnormal muscle cell glucose uptake | 6.72e-05 | 67 | 212 | 7 | MP:0004130 | |
| MousePheno | abnormal glycogen homeostasis | 6.83e-05 | 144 | 212 | 10 | MP:0005438 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | SMG1 STAG1 INPP4A RC3H1 MCM4 NEB ARID1A KMT2C GRK2 GLI3 SCN2A SMG9 FGFR3 FGFR2 UNC79 CLUH ALPL DNM2 FLNA UBR4 USP24 GRIN2B CIT CREBBP PIKFYVE NCOR1 CELSR3 RTL1 ELMO2 SBDS DCHS1 NPRL3 LRP2 CCN2 SPEN GABBR1 HTT | 7.89e-05 | 1269 | 212 | 37 | MP:0011111 |
| MousePheno | abnormal adipose tissue amount | RALGAPA1 STAG1 PSG1 PSG2 PSG4 PSG9 NEXMIF PSG11 SEC24A NEB PRDM10 ADRB3 BRCA1 TBC1D1 C3 UNC79 ABHD16A ALPL ENOX1 GRIK1 PRDM4 PIAS2 CREBBP LEP NCOR1 LIPA TENM4 AKAP9 STAU2 EIF4G1 GPSM1 GABBR1 PADI3 | 7.96e-05 | 1077 | 212 | 33 | MP:0005452 |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 9.20e-05 | 49 | 212 | 6 | MP:0020948 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 9.43e-05 | 31 | 212 | 5 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 9.43e-05 | 31 | 212 | 5 | MP:0008964 | |
| MousePheno | failure of endochondral bone ossification | 1.15e-04 | 7 | 212 | 3 | MP:0008275 | |
| MousePheno | bowed fibula | 1.15e-04 | 7 | 212 | 3 | MP:0004372 | |
| MousePheno | abnormal vascular wound healing | 1.17e-04 | 73 | 212 | 7 | MP:0004883 | |
| MousePheno | abnormal tumor susceptibility | SMG1 STAG1 RAPH1 PSG1 PSG2 PSG4 PSG9 PSG11 RC3H1 FXYD5 PEX1 CUL9 MCM4 MGAT5 BRCA1 DEK RANBP2 POLE USP24 MSH3 CREBBP TIAM1 CDK5RAP2 | 1.39e-04 | 650 | 212 | 23 | MP:0002166 |
| MousePheno | decreased cellular glucose uptake | 1.44e-04 | 53 | 212 | 6 | MP:0003926 | |
| MousePheno | increased liver cholesterol level | 1.49e-04 | 34 | 212 | 5 | MP:0010027 | |
| MousePheno | abnormal fatty acid oxidation | 1.60e-04 | 54 | 212 | 6 | MP:0010953 | |
| MousePheno | increased tumor incidence | SMG1 STAG1 RAPH1 PSG1 PSG2 PSG4 PSG9 PSG11 RC3H1 PEX1 CUL9 MCM4 BRCA1 RANBP2 POLE USP24 MSH3 CREBBP TIAM1 CDK5RAP2 | 1.66e-04 | 530 | 212 | 20 | MP:0002020 |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.71e-04 | 35 | 212 | 5 | MP:0031618 | |
| MousePheno | embryonic lethality, incomplete penetrance | SMG1 STAG1 KIF4A DHX8 KMT2C GRK2 GLI3 ALPP NPR2 RBMS1 MED1 RFX3 CREBBP MFN1 PIKFYVE ELMO2 HTT | 1.73e-04 | 410 | 212 | 17 | MP:0011102 |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | SMG1 STAG1 KIF4A DHX8 KMT2C GRK2 GLI3 ALPP NPR2 RBMS1 MED1 RFX3 CREBBP MFN1 PIKFYVE ELMO2 HTT | 1.73e-04 | 410 | 212 | 17 | MP:0031660 |
| MousePheno | abnormal CNS synaptic transmission | SCN11A ATP6V1C1 GRIPAP1 INPP4A NEXMIF SPTBN2 PCDH17 DHX8 BPTF CLPTM1L SCN2A NUFIP2 NSUN5P2 C3 GRIN3A BSN PHF21B ATF7 POLE2 APBA1 GRIK1 VPS54 GRIN2B CREBBP NETO1 STAU2 EIF4G1 GABBR1 PINK1 EPHA5 | 1.94e-04 | 985 | 212 | 30 | MP:0002206 |
| MousePheno | abnormal muscle triglyceride level | 1.97e-04 | 36 | 212 | 5 | MP:0031412 | |
| MousePheno | abnormal incidence of induced tumors | STAG1 PSG1 PSG2 PSG4 PSG9 PSG11 FXYD5 CUL9 BRCA1 DEK RANBP2 USP24 TIAM1 | 2.38e-04 | 269 | 212 | 13 | MP:0013151 |
| MousePheno | abnormal muscle physiology | RALGAPA1 DCAF6 PSG1 PSG2 PSG4 PSG9 INPP4A PSG11 MDGA2 NEB MEF2C GRK2 TBC1D1 SCN5A BSN DNM2 DOCK1 NPR1 NPR2 VPS54 PRDM4 RFX3 CIT LEP KLHL31 ELMO2 ASXL3 GPSM1 GAA | 2.58e-04 | 954 | 212 | 29 | MP:0002106 |
| MousePheno | abnormal tumor incidence | SMG1 STAG1 RAPH1 PSG1 PSG2 PSG4 PSG9 PSG11 RC3H1 FXYD5 PEX1 CUL9 MCM4 BRCA1 DEK RANBP2 POLE USP24 MSH3 CREBBP TIAM1 CDK5RAP2 | 2.62e-04 | 635 | 212 | 22 | MP:0002019 |
| MousePheno | synostosis | 2.70e-04 | 9 | 212 | 3 | MP:0000566 | |
| MousePheno | abnormal lipid oxidation | 3.14e-04 | 61 | 212 | 6 | MP:0010951 | |
| MousePheno | abnormal synaptic transmission | SCN11A ATP6V1C1 GRIPAP1 TRPM7 INPP4A NEXMIF SPTBN2 PCDH17 DHX8 BPTF CLPTM1L SCN2A NUFIP2 NSUN5P2 C3 GRIN3A BSN PHF21B ATF7 POLE2 APBA1 GRIK1 VPS54 GRIN2B CREBBP NETO1 STAU2 EIF4G1 GABBR1 PINK1 EPHA5 | 3.61e-04 | 1070 | 212 | 31 | MP:0003635 |
| MousePheno | decreased heart atrium size | 3.81e-04 | 10 | 212 | 3 | MP:0031577 | |
| MousePheno | heart atrium hypoplasia | 3.81e-04 | 10 | 212 | 3 | MP:0004055 | |
| MousePheno | abnormal ventricle myocardium morphology | 3.83e-04 | 116 | 212 | 8 | MP:0010499 | |
| MousePheno | abnormal synaptic physiology | SCN11A ATP6V1C1 GRIPAP1 TRPM7 INPP4A NEXMIF SPTBN2 PCDH17 DHX8 BPTF CLPTM1L SCN2A NUFIP2 NSUN5P2 C3 GRIN3A BSN PHF21B ATF7 POLE2 APBA1 GRIK1 VPS54 GRIN2B CREBBP NETO1 STAU2 EIF4G1 GABBR1 PINK1 EPHA5 | 3.97e-04 | 1076 | 212 | 31 | MP:0021009 |
| MousePheno | increased insulin secretion | 4.09e-04 | 64 | 212 | 6 | MP:0003058 | |
| MousePheno | neoplasm | SMG1 STAG1 RAPH1 PSG1 PSG2 PSG4 PSG9 PSG11 RC3H1 FXYD5 PEX1 CUL9 MCM4 MGAT5 BRCA1 DEK RANBP2 POLE USP24 MSH3 CREBBP LEP TIAM1 CDK5RAP2 | 4.15e-04 | 747 | 212 | 24 | MP:0002006 |
| MousePheno | abnormal prenatal growth/weight/body size | SMG1 STAG1 TRPM7 MAP3K20 KIF4A MCM4 ARID1A MEF2C HIRA NUP54 BPTF GRK2 BRCA1 GLI3 SCN5A NUFIP2 SMG9 C3 FGFR2 CLUH ALPP RBMS1 UBR4 GRB10 VPS54 NCSTN MED1 CREBBP MFN1 PIKFYVE NCOR1 C2CD3 TENM4 RTL1 ANO6 SBDS NPRL3 LRP2 HTT | 4.85e-04 | 1493 | 212 | 39 | MP:0004196 |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 5.14e-04 | 44 | 212 | 5 | MP:0031023 | |
| MousePheno | abnormal colon morphology | 5.17e-04 | 152 | 212 | 9 | MP:0000495 | |
| MousePheno | abnormal carbon dioxide production | 5.24e-04 | 67 | 212 | 6 | MP:0008962 | |
| MousePheno | abnormal myocardium compact layer morphology | 5.24e-04 | 67 | 212 | 6 | MP:0004056 | |
| MousePheno | abnormal myocardium layer morphology | ARID1A MEF2C GRK2 SCN5A SMG9 FGFR2 NPR1 VPS54 MED1 CREBBP LEP PIKFYVE ASXL3 NPRL3 LRP2 GAA | 5.84e-04 | 414 | 212 | 16 | MP:0005329 |
| MousePheno | abnormal lung morphology | SMG1 RC3H1 CUL9 MCM4 SERPINB10 GLI3 SCN5A SCNN1G FGFR3 FGFR2 DOCK1 FLNA RANBP2 POLE USP24 GRB10 MED1 CREBBP PIKFYVE LIPA CELSR3 DCHS1 LRP2 CCN2 | 6.05e-04 | 767 | 212 | 24 | MP:0001175 |
| MousePheno | increased food intake | 6.21e-04 | 189 | 212 | 10 | MP:0011939 | |
| MousePheno | abnormal hyaline cartilage morphology | 6.33e-04 | 46 | 212 | 5 | MP:0006429 | |
| MousePheno | thin myocardium compact layer | 6.33e-04 | 46 | 212 | 5 | MP:0004057 | |
| MousePheno | thick nasal septum | 6.80e-04 | 3 | 212 | 2 | MP:0030205 | |
| MousePheno | heart left atrium hypoplasia | 6.80e-04 | 3 | 212 | 2 | MP:0010647 | |
| MousePheno | decreased heart left atrium size | 6.80e-04 | 3 | 212 | 2 | MP:0031578 | |
| MousePheno | increased urine bicarbonate level | 6.80e-04 | 3 | 212 | 2 | MP:0011462 | |
| MousePheno | abnormal urine bicarbonate level | 6.80e-04 | 3 | 212 | 2 | MP:0011461 | |
| MousePheno | prognathia | 6.80e-04 | 3 | 212 | 2 | MP:0010208 | |
| MousePheno | increased urine microglobulin level | 6.80e-04 | 3 | 212 | 2 | MP:0011555 | |
| MousePheno | split sternal manubrium | 6.80e-04 | 3 | 212 | 2 | MP:0012667 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 6.99e-04 | 47 | 212 | 5 | MP:0031617 | |
| MousePheno | ventricle myocardium hypoplasia | 7.15e-04 | 71 | 212 | 6 | MP:0010502 | |
| MousePheno | increased classified tumor incidence | SMG1 STAG1 RAPH1 RC3H1 PEX1 CUL9 MCM4 BRCA1 RANBP2 POLE USP24 MSH3 CREBBP TIAM1 CDK5RAP2 | 7.16e-04 | 381 | 212 | 15 | MP:0010273 |
| MousePheno | abnormal heart layer morphology | ARID1A MEF2C GRK2 SCN5A SMG9 FGFR2 NPR1 VPS54 MED1 CREBBP LEP PIKFYVE ASXL3 NPRL3 LRP2 GAA | 7.17e-04 | 422 | 212 | 16 | MP:0010545 |
| MousePheno | abnormal prenatal body size | SMG1 STAG1 TRPM7 KIF4A ARID1A HIRA BPTF GRK2 BRCA1 GLI3 SCN5A NUFIP2 SMG9 C3 FGFR2 CLUH RBMS1 UBR4 GRB10 NCSTN MED1 CREBBP MFN1 PIKFYVE NCOR1 C2CD3 ANO6 SBDS NPRL3 LRP2 HTT | 7.34e-04 | 1116 | 212 | 31 | MP:0010866 |
| MousePheno | abnormal classified tumor incidence | SMG1 STAG1 RAPH1 RC3H1 PEX1 CUL9 MCM4 BRCA1 RANBP2 POLE USP24 MSH3 CREBBP TIAM1 CDK5RAP2 | 7.76e-04 | 384 | 212 | 15 | MP:0020188 |
| MousePheno | bowed ulna | 8.79e-04 | 13 | 212 | 3 | MP:0004361 | |
| MousePheno | abnormal eating behavior | PSG1 PSG2 PSG4 PSG9 PSG11 NEB ADRB3 SCN2A C3 FGFR3 UNC79 DNM2 GRIN2B LEP SNX29 ARAF NCOR1 LIPA TNN GPSM1 | 8.82e-04 | 604 | 212 | 20 | MP:0001431 |
| MousePheno | abnormal cellular glucose uptake | 9.13e-04 | 102 | 212 | 7 | MP:0003925 | |
| MousePheno | abnormal digestive system morphology | RAPH1 PSG1 PSG2 PSG4 PSG9 PSG11 RC3H1 SYTL2 MCM4 BCR BRCA1 GLI3 C3 FGFR3 FGFR2 ALPL IGSF3 DNM2 FLNA NPR2 POLE MSH3 CREBBP LEP ARAF STPG4 LIPA MIDN CELSR3 DCHS1 NPRL3 LRP2 CCN2 | 9.28e-04 | 1233 | 212 | 33 | MP:0000462 |
| Domain | ARM-type_fold | RALGAPA1 SMG1 STAG1 CUL9 TOGARAM1 CLASP2 ARID1A UNC79 DOCK1 DOCK2 PPP4R1 RELCH COPG1 UBR4 USP24 ELMO2 VPS35 EIF4G1 IPO13 LRBA HTT | 1.04e-08 | 339 | 257 | 21 | IPR016024 |
| Domain | HEAT_REPEAT | 5.21e-06 | 70 | 257 | 8 | PS50077 | |
| Domain | Ig_2 | 7.16e-06 | 73 | 257 | 8 | PF13895 | |
| Domain | Peripla_BP_I | 1.43e-05 | 39 | 257 | 6 | IPR028082 | |
| Domain | ARM-like | SMG1 STAG1 CUL9 TOGARAM1 CLASP2 ARID1A DOCK2 PPP4R1 RELCH COPG1 ELMO2 IPO13 LRBA HTT | 2.39e-05 | 270 | 257 | 14 | IPR011989 |
| Domain | ANF_lig-bd_rcpt | 1.44e-04 | 37 | 257 | 5 | IPR001828 | |
| Domain | ANF_receptor | 1.44e-04 | 37 | 257 | 5 | PF01094 | |
| Domain | Cysteine_dSase | 1.89e-04 | 2 | 257 | 2 | IPR016454 | |
| Domain | - | CUL9 TOGARAM1 CLASP2 ARID1A PPP4R1 RELCH COPG1 ELMO2 IPO13 LRBA HTT | 2.65e-04 | 222 | 257 | 11 | 1.25.10.10 |
| Domain | Na_channel_asu | 2.88e-04 | 10 | 257 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 2.88e-04 | 10 | 257 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 2.88e-04 | 10 | 257 | 3 | PF06512 | |
| Domain | Pkinase_Tyr | 4.19e-04 | 129 | 257 | 8 | PF07714 | |
| Domain | IGc2 | PSG1 PSG2 PSG4 PSG9 PSG11 MDGA2 FGFR3 FGFR2 IGSF3 FCRL6 CD22 | 4.30e-04 | 235 | 257 | 11 | SM00408 |
| Domain | Ig_sub2 | PSG1 PSG2 PSG4 PSG9 PSG11 MDGA2 FGFR3 FGFR2 IGSF3 FCRL6 CD22 | 4.30e-04 | 235 | 257 | 11 | IPR003598 |
| Domain | ANF_RECEPTORS | 5.61e-04 | 3 | 257 | 2 | PS00458 | |
| Domain | ANPR/GUC | 5.61e-04 | 3 | 257 | 2 | IPR001170 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 6.57e-04 | 138 | 257 | 8 | IPR001245 | |
| Domain | Ig-like_fold | PSG1 PSG2 PSG4 PSG9 PSG11 MDGA2 FNDC1 CD101 MID1 FGFR3 FGFR2 IGKV4-1 PLXNA1 IGSF3 FLNA FCRL6 MILR1 CD22 TNN IL3RA EPHA5 | 7.97e-04 | 706 | 257 | 21 | IPR013783 |
| Domain | G_DYNAMIN_dom | 8.38e-04 | 14 | 257 | 3 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 8.38e-04 | 14 | 257 | 3 | PS51718 | |
| Domain | SEA | 8.38e-04 | 14 | 257 | 3 | SM00200 | |
| Domain | PH_dom-like | RAPH1 MYO7B SPTBN2 EPB41L4A BCR GRK2 TBC1D1 DNM2 RANBP2 APBA1 GRB10 CIT TIAM1 ELMO2 LRBA | 8.68e-04 | 426 | 257 | 15 | IPR011993 |
| Domain | - | PSG1 PSG2 PSG4 PSG9 PSG11 MDGA2 FNDC1 CD101 MID1 FGFR3 FGFR2 PLXNA1 IGSF3 FLNA FCRL6 MILR1 CD22 TNN IL3RA EPHA5 | 8.94e-04 | 663 | 257 | 20 | 2.60.40.10 |
| Domain | Znf_FYVE_PHD | 9.92e-04 | 147 | 257 | 8 | IPR011011 | |
| Domain | EGF-like_CS | MUC3B CRB1 MMRN1 EYS TENM4 CELSR3 TNN TENM1 LRP2 MUC3A EPHA5 | 1.02e-03 | 261 | 257 | 11 | IPR013032 |
| Domain | Dynamin_GTPase | 1.04e-03 | 15 | 257 | 3 | IPR001401 | |
| Domain | Dynamin_SF | 1.04e-03 | 15 | 257 | 3 | IPR022812 | |
| Domain | Dynamin_N | 1.04e-03 | 15 | 257 | 3 | PF00350 | |
| Domain | - | RAPH1 MYO7B SPTBN2 EPB41L4A BCR GRK2 TBC1D1 DNM2 RANBP2 APBA1 GRB10 CIT TIAM1 ELMO2 | 1.09e-03 | 391 | 257 | 14 | 2.30.29.30 |
| Domain | Tox-GHH_dom | 1.11e-03 | 4 | 257 | 2 | IPR028916 | |
| Domain | Alk_phosphatase | 1.11e-03 | 4 | 257 | 2 | PF00245 | |
| Domain | Alkaline_phosphatase_AS | 1.11e-03 | 4 | 257 | 2 | IPR018299 | |
| Domain | Tox-GHH | 1.11e-03 | 4 | 257 | 2 | PF15636 | |
| Domain | Ten_N | 1.11e-03 | 4 | 257 | 2 | PF06484 | |
| Domain | TENEURIN_N | 1.11e-03 | 4 | 257 | 2 | PS51361 | |
| Domain | alkPPc | 1.11e-03 | 4 | 257 | 2 | SM00098 | |
| Domain | ALKALINE_PHOSPHATASE | 1.11e-03 | 4 | 257 | 2 | PS00123 | |
| Domain | Ten_N | 1.11e-03 | 4 | 257 | 2 | IPR009471 | |
| Domain | Alkaline_phosphatase | 1.11e-03 | 4 | 257 | 2 | IPR001952 | |
| Domain | FGF_rcpt_fam | 1.11e-03 | 4 | 257 | 2 | IPR016248 | |
| Domain | EGF_2 | MUC3B CRB1 MMRN1 EYS TENM4 CELSR3 TNN TENM1 LRP2 MUC3A EPHA5 | 1.16e-03 | 265 | 257 | 11 | PS01186 |
| Domain | HEAT | 1.20e-03 | 58 | 257 | 5 | IPR000357 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 2.15e-05 | 26 | 189 | 5 | M2499 | |
| Pubmed | SPTBN2 KIF4A CUL9 MCM4 ARID1A ANKHD1 DHX8 BPTF ANAPC1 NUFIP2 CLUH NUP160 DNM2 FLNA RANBP2 COPG1 DHX37 POLE UBR4 USP24 IARS2 WDR6 EIF4G1 PDCD11 MACF1 SPEN | 5.99e-12 | 653 | 261 | 26 | 22586326 | |
| Pubmed | DCAF6 PDE9A STAG1 TRPM7 SPTBN2 CUL9 NCKAP5 ARMCX4 ARID1A PRMT2 ALPL DNM2 PPP4R1 UBR4 APBA1 GRIK1 MSH3 VPS54 GRIN2B PRDM4 PIAS2 USP16 CIT CREBBP CELSR3 TIAM1 NETO1 EIF4A2 EIF4G1 LRP2 MACF1 CCN2 LRBA USPL1 PINK1 | 5.11e-11 | 1285 | 261 | 35 | 35914814 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXR1 STAG1 KIF4A CUL9 MCM4 ANKHD1 MEF2C HIRA CRACD BPTF PRDM10 ANAPC1 MGA DEK NUP160 ATF7 RANBP2 COPG1 POLE UBR4 MSH3 RFX3 CREBBP NCOR1 IARS2 EIF4G1 SPEN GAA | 8.92e-11 | 857 | 261 | 28 | 25609649 |
| Pubmed | RAPH1 RPN1 SPTBN2 KIF4A ARID1A ANKHD1 BPTF KMT2C ANAPC1 RAB3GAP2 NUFIP2 MGA FLNA USP24 MED1 CREBBP NCOR1 WDR6 PDCD11 LRBA SPEN HTT | 2.42e-10 | 549 | 261 | 22 | 38280479 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RC3H1 ANKHD1 BCR HIRA DHX8 GRK2 BRCA1 ANAPC1 NUFIP2 SMG9 MGA CLUH FLNA RANBP2 COPG1 DHX37 RBMS1 MED1 USP16 WDR6 SBDS STAU2 EIF4G1 MACF1 SPEN | 3.10e-10 | 724 | 261 | 25 | 36232890 |
| Pubmed | CUL9 NCKAP5 BRCA1 DNM2 DOCK1 FLNA PPFIA4 GRB10 PCDHA12 NFS1 CELSR3 LRP2 LRBA SPEN PRG4 IL3RA GABBR1 | 6.42e-10 | 329 | 261 | 17 | 17474147 | |
| Pubmed | Insulin acutely decreases hepatic fatty acid synthase activity. | 7.98e-10 | 15 | 261 | 6 | 16054098 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CUL9 CLASP2 ZNF236 ARID1A ANKHD1 BCR HIRA KMT2C EIF2B3 SCN5A FGFR2 PLXNA1 RIC1 IGSF3 FLNA POLE UBR4 GRB10 CIT PIKFYVE NCOR1 C2CD3 CELSR3 EIF4G1 NPRL3 PDCD11 LRRC14 LRBA SPEN HTT | 1.48e-09 | 1105 | 261 | 30 | 35748872 |
| Pubmed | FAM91A1 MCM4 DHX8 NUP54 PRDM10 ANAPC1 RAB3GAP2 EIF2B3 CLUH NUP160 DNM2 COPG1 LRRC40 MSH3 NFS1 NCOR1 WDR6 ELMO2 VPS35 STAU2 EIF4G1 | 2.05e-09 | 560 | 261 | 21 | 35241646 | |
| Pubmed | RAPH1 INPP4A ANKHD1 BCR ANAPC1 RAB3GAP2 MGA FLNA RANBP2 UBR4 USP24 PIAS2 ARAF NCOR1 WDR6 N4BP2 LRP2 LRBA | 3.59e-09 | 418 | 261 | 18 | 34709266 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | RPN1 ARID1A HIRA NUP54 BPTF KMT2C MGA RANBP2 MSH3 RFX7 PIAS2 CREBBP NCOR1 WDR6 ASXL3 SPEN | 1.22e-08 | 351 | 261 | 16 | 38297188 |
| Pubmed | SMG1 SCN11A STAG1 RAPH1 RPN1 SPTBN2 ATP10B TKTL1 NEB LRRC43 ARID1A NUP54 EHD4 BPTF CLCN5 BRCA1 BSN FLNA RANBP2 PPFIA4 UBR4 NCOR1 C2CD3 N4BP2 TNN EIF4A2 VPS35 EIF4G1 TENM1 CES3 MACF1 USPL1 SPEN | 1.42e-08 | 1442 | 261 | 33 | 35575683 | |
| Pubmed | SMG1 NEB ARID1A CLPTM1L BSN IGSF3 DNM2 TRAPPC11 POLE UBR4 USP24 MUC16 MED1 PIAS2 SAR1A CREBBP CDY1 NCOR1 ASXL3 CDK5RAP2 SPEN | 1.97e-08 | 638 | 261 | 21 | 31182584 | |
| Pubmed | In vivo validation of late-onset Alzheimer's disease genetic risk factors. | 2.65e-08 | 25 | 261 | 6 | 38687251 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 2.81e-08 | 13 | 261 | 5 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 2.81e-08 | 13 | 261 | 5 | 19273835 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 20044046 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 32150576 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 2.81e-08 | 13 | 261 | 5 | 12832451 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 25406283 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 8380065 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 1279194 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 25724769 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 2.81e-08 | 13 | 261 | 5 | 22092845 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 2.81e-08 | 13 | 261 | 5 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 2.81e-08 | 13 | 261 | 5 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 2.81e-08 | 13 | 261 | 5 | 23800882 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 2.81e-08 | 13 | 261 | 5 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 2.81e-08 | 13 | 261 | 5 | 39168268 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 8402684 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 2.81e-08 | 13 | 261 | 5 | 21949477 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 26219866 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 2133556 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 2.81e-08 | 13 | 261 | 5 | 19358828 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 2.81e-08 | 13 | 261 | 5 | 34058224 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 2.81e-08 | 13 | 261 | 5 | 23935487 | |
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 2.81e-08 | 13 | 261 | 5 | 25972571 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 2.81e-08 | 13 | 261 | 5 | 15220458 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 18843289 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 15207636 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 21081647 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 11133662 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 11483763 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 18003729 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 2.81e-08 | 13 | 261 | 5 | 27695943 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 2.81e-08 | 13 | 261 | 5 | 16638824 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 2.81e-08 | 13 | 261 | 5 | 21670291 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 22162753 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 2702644 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 11801635 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 21760897 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 1719235 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 16619040 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 2.81e-08 | 13 | 261 | 5 | 8209741 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 32521208 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 2.81e-08 | 13 | 261 | 5 | 29967450 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 1653760 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 32169849 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 2.81e-08 | 13 | 261 | 5 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 2.81e-08 | 13 | 261 | 5 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 2.81e-08 | 13 | 261 | 5 | 15316023 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 15331748 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 2.81e-08 | 13 | 261 | 5 | 22406619 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 7628460 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 19008452 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 2164599 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 29396368 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 2.81e-08 | 13 | 261 | 5 | 33352461 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 38381498 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 1633107 | ||
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 2.81e-08 | 13 | 261 | 5 | 32027621 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 2.81e-08 | 13 | 261 | 5 | 27777319 | |
| Pubmed | 2.81e-08 | 13 | 261 | 5 | 18848945 | ||
| Pubmed | SMG1 RPN1 SEC24A RC3H1 CUL9 ARID1A ANKHD1 MEF2C STAT4 HIRA NUP54 BPTF KMT2C BRCA1 GLI3 MGA DHX37 RBMS1 UBR4 RFX7 PIAS2 CIT CREBBP MRPL39 NCOR1 MIDN STAU2 EIF4G1 LRP2 PDCD11 CEP152 SPEN | 3.96e-08 | 1429 | 261 | 32 | 35140242 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | KIF4A MCM4 EHD4 BPTF ANAPC1 NUP160 FLNA RANBP2 COPG1 UBR4 MSH3 PIAS2 NCOR1 EIF4A2 EIF4G1 | 3.96e-08 | 332 | 261 | 15 | 32786267 |
| Pubmed | 4.34e-08 | 14 | 261 | 5 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 4.34e-08 | 14 | 261 | 5 | 34666041 | |
| Pubmed | 4.34e-08 | 14 | 261 | 5 | 34619794 | ||
| Pubmed | 4.34e-08 | 14 | 261 | 5 | 8896983 | ||
| Pubmed | 4.34e-08 | 14 | 261 | 5 | 22962327 | ||
| Pubmed | 4.34e-08 | 14 | 261 | 5 | 17623671 | ||
| Interaction | GRIN1 interactions | DCAF6 FGFR3 GRIN3A BSN DOCK1 GRIN2B CIT AKAP9 TIAM1 NETO1 ELMO2 HTT | 6.10e-07 | 154 | 254 | 12 | int:GRIN1 |
| Interaction | SIRT7 interactions | SPTBN2 KIF4A CUL9 MCM4 ARID1A ANKHD1 DHX8 BPTF ANAPC1 NUFIP2 CLUH NUP160 DNM2 FLNA RANBP2 COPG1 DHX37 POLE UBR4 USP24 IARS2 WDR6 EIF4G1 PDCD11 MACF1 SPEN | 2.83e-06 | 744 | 254 | 26 | int:SIRT7 |
| Interaction | SYNE3 interactions | TRPM7 RPN1 SEC24A RC3H1 PEX1 TOGARAM1 CLPTM1L ANAPC1 GLI3 TTC13 CLUH RANBP2 NCSTN NCOR1 C2CD3 N4BP2 MACF1 CDK5RAP2 CEP152 | 3.93e-06 | 444 | 254 | 19 | int:SYNE3 |
| Interaction | HDAC1 interactions | STAG1 RAPH1 TRPM7 KIF4A MCM4 ARID1A ANKHD1 BCR NUP54 BPTF BRCA1 GLI3 RAB3GAP2 CDYL MGA PHF21B PPP4R1 FLNA RANBP2 UBR4 USP24 PRDM4 RFX3 CIT CREBBP ARAF NCOR1 AKAP9 WDR6 CDK5RAP2 LRBA SPEN | 1.06e-05 | 1108 | 254 | 32 | int:HDAC1 |
| Interaction | RAC1 interactions | RALGAPA1 RAPH1 TRPM7 RPN1 SPTBN2 FAM91A1 BCR PCDH17 EHD4 FZD6 NUP160 PLXNA1 ALPL IGSF3 DOCK1 DOCK2 FLNA CARMIL1 GRIN2B CIT PIKFYVE MIDN TIAM1 WDR6 ELMO2 ANO6 LRP2 MACF1 LRBA HTT EPHA5 | 1.22e-05 | 1063 | 254 | 31 | int:RAC1 |
| Interaction | CELSR3 interactions | 2.32e-05 | 46 | 254 | 6 | int:CELSR3 | |
| Interaction | H2AC4 interactions | MCM4 ARID1A ANKHD1 EHD4 KMT2C PRDM10 COMMD4 BRCA1 ANAPC1 CDYL UNC79 DNM2 USP16 CIT CREBBP APLF USF3 PDCD11 PINK1 | 2.47e-05 | 506 | 254 | 19 | int:H2AC4 |
| Interaction | C9orf78 interactions | FAM91A1 MCM4 DHX8 NUP54 PRDM10 ANAPC1 RAB3GAP2 EIF2B3 CLUH NUP160 DNM2 COPG1 LRRC40 MSH3 NFS1 NCOR1 WDR6 ELMO2 VPS35 STAU2 EIF4G1 | 4.20e-05 | 620 | 254 | 21 | int:C9orf78 |
| Interaction | TOP3B interactions | SEC24A SPTBN2 CUL9 CLASP2 ZNF236 ARID1A ANKHD1 BCR HIRA KMT2C EIF2B3 SCN5A NUFIP2 FGFR2 PLXNA1 RIC1 IGSF3 FLNA RBMS1 POLE UBR4 APBA1 GRB10 MSH3 CIT PIKFYVE NCOR1 C2CD3 CELSR3 EIF4A2 EIF4G1 NPRL3 PDCD11 LRRC14 LRBA SPEN HTT | 4.28e-05 | 1470 | 254 | 37 | int:TOP3B |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 4.07e-08 | 11 | 180 | 5 | 1315 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 7.80e-05 | 9 | 180 | 3 | 1203 | |
| GeneFamily | Nucleoporins | 2.75e-04 | 32 | 180 | 4 | 1051 | |
| GeneFamily | Parkinson disease associated genes | 4.94e-04 | 16 | 180 | 3 | 672 | |
| GeneFamily | Alkaline phosphatases | 5.84e-04 | 4 | 180 | 2 | 1072 | |
| GeneFamily | CD molecules|Mucins | 1.13e-03 | 21 | 180 | 3 | 648 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.25e-03 | 163 | 180 | 7 | 590 | |
| GeneFamily | Guanylate cyclase receptors | 2.00e-03 | 7 | 180 | 2 | 343 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 2.00e-03 | 7 | 180 | 2 | 1201 | |
| GeneFamily | PHD finger proteins | 2.05e-03 | 90 | 180 | 5 | 88 | |
| GeneFamily | Regulatory factor X family | 2.65e-03 | 8 | 180 | 2 | 1153 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.39e-03 | 9 | 180 | 2 | 1234 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | RALGAPA1 SMG1 ARID1A BPTF KMT2C PRDM10 BRCA1 RIC1 POLE USP24 RFX7 CREBBP NCOR1 MACF1 | 3.55e-09 | 180 | 259 | 14 | M8239 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GALK2 STAG1 SEC24A TOGARAM1 CLASP2 HIRA BPTF MGAT5 BRCA1 MID1 CDYL DEK NUP160 DOCK1 RANBP2 RBMS1 USP24 MSH3 MED1 CREBBP PIKFYVE C2CD3 AKAP9 TIAM1 STAU2 MACF1 CCN2 SPEN | 3.36e-08 | 856 | 259 | 28 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 SMG1 INPP4A FXYD5 EVI2A ARID1A TESPA1 STAT4 BPTF KMT2C GRK2 TBC1D1 RAB3GAP2 CD101 NUFIP2 PRMT2 DEK DOCK2 FLNA RANBP2 RBMS1 UBR4 USP24 MED1 RFX7 SP110 CREBBP FCRL6 PIKFYVE NCOR1 AKAP9 ELMO2 EIF4A2 PTAR1 GZMK MACF1 LRBA SPEN | 8.28e-08 | 1492 | 259 | 38 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | STAG1 SEC24A CLASP2 HIRA BPTF MGAT5 BRCA1 MID1 CDYL RBMS1 USP24 CREBBP PIKFYVE C2CD3 AKAP9 TIAM1 STAU2 CCN2 SPEN | 2.30e-07 | 466 | 259 | 19 | M13522 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RAPH1 INPP4A SYTL2 PEX1 MDGA2 NEB PCDH17 EHD4 MGAT5 KLHL13 SCN2A TOX3 GRIN3A BSN UNC79 PLXNA1 IGSF3 ENOX1 PPFIA4 APBA1 GRIK1 RFX7 PIAS2 AKAP9 CELSR3 NETO1 N4BP2 ASXL3 TENM1 | 1.85e-06 | 1106 | 259 | 29 | M39071 |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 7.61e-06 | 48 | 259 | 6 | MM531 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.44e-05 | 182 | 259 | 10 | MM993 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 1.47e-05 | 32 | 259 | 5 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 2.31e-05 | 35 | 259 | 5 | MM757 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 3.06e-05 | 159 | 259 | 9 | MM760 | |
| Coexpression | GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN | KDM5D ZNF236 ARID1A KMT2C TBC1D1 PPP4R1 PIKFYVE NETO1 USPL1 SPEN | 3.11e-05 | 199 | 259 | 10 | M3517 |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN | 3.24e-05 | 200 | 259 | 10 | M8032 | |
| Coexpression | GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_DN | 3.24e-05 | 200 | 259 | 10 | M8584 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP | ANKHD1 MID1 MGA RELCH LRRC40 VPS54 MRPL39 AKAP9 VPS35 ZNF445 | 3.24e-05 | 200 | 259 | 10 | M6584 |
| Coexpression | GSE7852_LN_VS_FAT_TCONV_UP | 3.24e-05 | 200 | 259 | 10 | M5747 | |
| Coexpression | GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 4.30e-05 | 166 | 259 | 9 | M9100 | |
| Coexpression | SANSOM_APC_TARGETS | 4.71e-05 | 209 | 259 | 10 | M1755 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | PSG1 PSG2 PSG4 PSG9 PSG11 FGFR2 MGA DNM2 RBMS1 GRB10 SAR1A LEP MRPL39 TENM4 EIF4G1 GPSM1 PINK1 EPHA5 PCOLCE ZNF445 | 5.32e-05 | 741 | 259 | 20 | MM1037 |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 6.13e-05 | 135 | 259 | 8 | MM965 | |
| Coexpression | DITTMER_PTHLH_TARGETS_DN | 6.79e-05 | 70 | 259 | 6 | M18667 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 1.00e-04 | 75 | 259 | 6 | MM605 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 1.08e-04 | 187 | 259 | 9 | M6807 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | KIF4A MCM4 BPTF GLI3 KLHL13 MID1 TOX3 FGFR2 DOCK1 POLE POLE2 CIT MRPL39 LRP2 | 1.12e-04 | 432 | 259 | 14 | MM419 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | INPP4A MAP3K20 MEF2C PCDH17 EHD4 KMT2C MGAT5 TBC1D1 RAB3GAP2 CDYL RBMS1 VPS54 CREBBP ARAF NCOR1 LIPA PTAR1 MACF1 CCN2 LRBA PCOLCE | 1.28e-04 | 854 | 259 | 21 | M1533 |
| Coexpression | GSE360_L_MAJOR_VS_T_GONDII_MAC_UP | 1.59e-04 | 197 | 259 | 9 | M5243 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION | 1.64e-04 | 82 | 259 | 6 | M16458 | |
| Coexpression | SANSOM_APC_TARGETS | 1.75e-04 | 245 | 259 | 10 | MM735 | |
| Coexpression | STARK_HYPPOCAMPUS_22Q11_DELETION_UP | 1.77e-04 | 53 | 259 | 5 | MM582 | |
| Coexpression | GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP | 1.79e-04 | 200 | 259 | 9 | M9397 | |
| Coexpression | GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN | 1.79e-04 | 200 | 259 | 9 | M6789 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | RALGAPA1 SMG1 INPP4A SEC24A MCM4 ANKHD1 MEF2C PRDM10 MGAT5 TBC1D1 RAB3GAP2 CDYL TTC13 FGFR2 NUP160 ATF7 RBMS1 TMED7 LRRC40 MSH3 SP110 MFN1 MMRN1 ELMO2 MACF1 LRBA | 1.92e-04 | 1215 | 259 | 26 | M41122 |
| Coexpression | STARK_HYPPOCAMPUS_22Q11_DELETION_UP | 1.93e-04 | 54 | 259 | 5 | M12050 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ATP6V1C1 RAPH1 NEXMIF TOGARAM1 CLASP2 CRACD KMT2C PRMT2 UNC79 RANBP2 NPR2 PRDM4 SNX29 PIKFYVE USF3 TIAM1 ELMO2 SBDS EIF4A2 VPS35 PTAR1 GPSM1 | 1.95e-04 | 946 | 259 | 22 | M39169 |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION | 2.00e-04 | 85 | 259 | 6 | MM1106 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | GALK2 STAG1 RAPH1 NEXMIF KIF4A FAM91A1 MCM4 TMEM71 DHX8 ADRB3 BRCA1 GLE1 KLHL13 SCNN1G CDYL DEK NUP160 ATF7 POLE2 GRB10 PIAS2 MRPL39 N4BP2 STAU2 CEP152 USPL1 RNF182 | 2.06e-04 | 1290 | 259 | 27 | M80 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | INPP4A MAP3K20 MEF2C PCDH17 EHD4 KMT2C MGAT5 TBC1D1 RAB3GAP2 CDYL RBMS1 VPS54 CREBBP ARAF NCOR1 LIPA PTAR1 MACF1 CCN2 LRBA PCOLCE | 2.18e-04 | 888 | 259 | 21 | MM1018 |
| Coexpression | GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN | 2.37e-04 | 164 | 259 | 8 | M8989 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | RALGAPA1 SMG1 SYTL2 STAT4 TXK BPTF RELCH USP24 AKAP9 TENM1 MACF1 LRBA | 2.38e-09 | 199 | 260 | 12 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B MDGA2 NEB SCN2A UNC79 GRIN2B TENM4 ASXL3 TENM1 LRP2 EPHA5 | 1.22e-08 | 184 | 260 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B MDGA2 NEB SCN2A UNC79 GRIN2B TENM4 ASXL3 TENM1 LRP2 EPHA5 | 1.22e-08 | 184 | 260 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B MDGA2 NEB SCN2A UNC79 GRIN2B TENM4 ASXL3 TENM1 LRP2 EPHA5 | 1.22e-08 | 184 | 260 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | RALGAPA1 SMG1 TRPM7 STAT4 KMT2C NUFIP2 RANBP2 USP24 MACF1 LRBA SPEN | 1.52e-08 | 188 | 260 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | RALGAPA1 ARID1A BPTF MGA RANBP2 MSH3 MED1 USF3 AKAP9 N4BP2 PTAR1 | 2.00e-08 | 193 | 260 | 11 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SMG1 INPP4A SYTL2 STAT4 TXK RELCH USP24 RFX3 AKAP9 MACF1 LRBA | 2.00e-08 | 193 | 260 | 11 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SMG1 SYTL2 STAT4 TXK KMT2C USP24 RFX3 AKAP9 TENM1 MACF1 LRBA | 2.47e-08 | 197 | 260 | 11 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-07 | 145 | 260 | 9 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.43e-07 | 164 | 260 | 9 | 6a113191ea91d103d21c5f056b1950217688ea26 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.01e-07 | 166 | 260 | 9 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 8.92e-07 | 174 | 260 | 9 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.55e-06 | 186 | 260 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-06 | 187 | 260 | 9 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-06 | 187 | 260 | 9 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 194 | 260 | 9 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-06 | 194 | 260 | 9 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 194 | 260 | 9 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 198 | 260 | 9 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 157 | 260 | 8 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.89e-06 | 161 | 260 | 8 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.12e-06 | 162 | 260 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.12e-06 | 162 | 260 | 8 | 9d6931619f5eb847c79d00ff5ae031fef30fd55c | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.99e-06 | 169 | 260 | 8 | da607c1d068038d5a3d1117f6aa6e4c6f3552e97 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.99e-06 | 169 | 260 | 8 | a14b46231e079a0fd9f3ca13d5d48113be76fd0f | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.99e-06 | 169 | 260 | 8 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.95e-06 | 172 | 260 | 8 | 26006967d0c82f7bd9b36a18e97a1b93e856aa67 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.95e-06 | 172 | 260 | 8 | a9e65201ad9ab4f64251aba2c0bb3d8f9e0193b6 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.95e-06 | 172 | 260 | 8 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | facs-Skin-nan-24m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-06 | 174 | 260 | 8 | 6863222bec844f40c0c80f5c82a8ff51d1a56d0a | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-06 | 174 | 260 | 8 | 1c073177c1753e3b91ef8fd9e95230a1d13c82f3 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.65e-06 | 174 | 260 | 8 | 66555c610251ea04f968c258e312d720c18e7cde | |
| ToppCell | facs-Skin-nan-24m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-06 | 174 | 260 | 8 | 5739c1b8d643ad360ef32049832d749c530ca603 | |
| ToppCell | facs-Skin-nan-24m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-06 | 174 | 260 | 8 | d570eab215f8287362084e37f35672e20aa0f7a2 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-06 | 174 | 260 | 8 | 5491ad5c144baf2ef9b1c58eb720c872d14feb15 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 9.41e-06 | 176 | 260 | 8 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 179 | 260 | 8 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 180 | 260 | 8 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 180 | 260 | 8 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-05 | 180 | 260 | 8 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 180 | 260 | 8 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.20e-05 | 182 | 260 | 8 | f2a1784ffcba9b27132e0db21e574cbd8a0a6418 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-05 | 183 | 260 | 8 | 9d5a363fbe6f0a1668c9d584df65ee1c283349c7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-05 | 183 | 260 | 8 | c5caac6ed6c8d67f5c336281d9fd903976509445 | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 1.35e-05 | 185 | 260 | 8 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 185 | 260 | 8 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 186 | 260 | 8 | 1850583d23903d08226aeb0edb3e07b0994330e4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 186 | 260 | 8 | 4dafc215c42e7949f932a3627359c107943b5d6b | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 187 | 260 | 8 | 908df5520142d65fe32a003d26be14965082a1ea | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 187 | 260 | 8 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 187 | 260 | 8 | c1dfab0b0d7f519b9f13f4e0365ab41c4b2ae1ec | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 187 | 260 | 8 | b486cc5ac678051fea9d4c7db53b26a5a8427e60 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.47e-05 | 135 | 260 | 7 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.52e-05 | 188 | 260 | 8 | 9655a4c47b644a870017d349b99063e17dbae572 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.52e-05 | 188 | 260 | 8 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | (2)_NK/T-(21)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 1.58e-05 | 189 | 260 | 8 | b37ad24898a14a4a3b2d6cea2637de2471f76e20 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 189 | 260 | 8 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | (2)_NK/T-(210)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 1.58e-05 | 189 | 260 | 8 | fa72e87e1e8cd7cbddae7b47e19cf90d181820a7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-05 | 189 | 260 | 8 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 190 | 260 | 8 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-05 | 190 | 260 | 8 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-05 | 190 | 260 | 8 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.64e-05 | 190 | 260 | 8 | a7498fe55b7810c482291db782dc5282675d246a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 190 | 260 | 8 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 191 | 260 | 8 | d9506b88d806aadd4c2b9bf86fe994c47799e7f6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 191 | 260 | 8 | 9aabbc65430e2233b8f2d3fff9face7807b88b48 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 191 | 260 | 8 | b42c54308abe1241cc38ddce96b9d38d07983891 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 191 | 260 | 8 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 191 | 260 | 8 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 191 | 260 | 8 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 191 | 260 | 8 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 192 | 260 | 8 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 192 | 260 | 8 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | (210)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.77e-05 | 192 | 260 | 8 | 08dc0c019c594da7b9944db8fd706aa7780e6ae9 | |
| ToppCell | (21)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.77e-05 | 192 | 260 | 8 | b0a573ddde2978485a857b8261ee1ee5ef68ecef | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-05 | 193 | 260 | 8 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-05 | 193 | 260 | 8 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-05 | 193 | 260 | 8 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.90e-05 | 194 | 260 | 8 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.90e-05 | 194 | 260 | 8 | 5031f324628ff12a33e84cc52157be4786e0961d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 194 | 260 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-05 | 194 | 260 | 8 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | (08)_PNEC-(2)_48hpi|(08)_PNEC / shred by cell type and Timepoint | 2.03e-05 | 142 | 260 | 7 | e95d34170f5053678e0dd9793e68d93c03b05822 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.05e-05 | 196 | 260 | 8 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-05 | 143 | 260 | 7 | 990844ca674d30b2924c74b45bed4fdfb8463fa7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-05 | 198 | 260 | 8 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 2.20e-05 | 198 | 260 | 8 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-05 | 198 | 260 | 8 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.29e-05 | 199 | 260 | 8 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 2.29e-05 | 199 | 260 | 8 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-05 | 199 | 260 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 199 | 260 | 8 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-05 | 199 | 260 | 8 | f0bf75bfae7b288ecb6801be458b03ebd0108ea7 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-05 | 200 | 260 | 8 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.37e-05 | 200 | 260 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.37e-05 | 200 | 260 | 8 | 306926cb7a847871641f02e03d52dc56fd55711c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.37e-05 | 200 | 260 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-05 | 200 | 260 | 8 | 8e41a484038216f0c2ad258fd46c0e702a4bb8bf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.37e-05 | 200 | 260 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 200 | 260 | 8 | c935caef2988f165e96d8f1ef99ae8963ab9377f | |
| Computational | Neighborhood of CDKN1C | 3.11e-06 | 27 | 169 | 6 | GNF2_CDKN1C | |
| Computational | Neighborhood of IGFBP1 | 1.54e-05 | 35 | 169 | 6 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 4.54e-05 | 42 | 169 | 6 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 7.69e-05 | 46 | 169 | 6 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 1.10e-04 | 49 | 169 | 6 | GNF2_KISS1 | |
| Computational | Neighborhood of EGFR | 1.29e-04 | 32 | 169 | 5 | GNF2_EGFR | |
| Computational | Neighborhood of REV3L | 2.84e-04 | 58 | 169 | 6 | MORF_REV3L | |
| Computational | Neighborhood of PTEN | 3.70e-04 | 85 | 169 | 7 | MORF_PTEN | |
| Computational | Neighborhood of RUNX1 | 6.51e-04 | 152 | 169 | 9 | MORF_RUNX1 | |
| Computational | Neighborhood of MLLT10 | STAG1 PSG1 ATP10B NEB BRCA1 GLE1 CDYL MGA GRIK1 MSH3 PIAS2 MFN1 TENM4 | 9.53e-04 | 302 | 169 | 13 | MORF_MLLT10 |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.87e-04 | 49 | 169 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.87e-04 | 49 | 169 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Disease | Malignant neoplasm of breast | CATSPERE RAPH1 CD109 ARID1A STAT4 CLPTM1L BRCA1 TOX3 FGFR2 DEK FLNA UBR4 SP110 LEP ARAF NCOR1 AKAP9 N4BP2 EIF4A2 TENM1 MACF1 LRBA SPEN RNF182 PADI3 | 7.76e-06 | 1074 | 255 | 25 | C0006142 |
| Disease | Colorectal Carcinoma | TRPM7 SPTBN2 CD109 ARID1A DNALI1 KMT2C GLI3 SCNN1G FGFR3 RELCH POLE MFN1 AKAP9 TIAM1 EIF4G1 TENM1 DCHS1 LRP2 RNF182 | 1.31e-05 | 702 | 255 | 19 | C0009402 |
| Disease | cD177 antigen measurement | 1.52e-05 | 18 | 255 | 4 | EFO_0021866 | |
| Disease | Carcinoma, Transitional Cell | 2.69e-05 | 41 | 255 | 5 | C0007138 | |
| Disease | Epilepsy | 4.67e-05 | 109 | 255 | 7 | C0014544 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 7.32e-05 | 10 | 255 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 7.32e-05 | 10 | 255 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Isolated coronal synostosis | 7.44e-05 | 2 | 255 | 2 | cv:CN043619 | |
| Disease | Epilepsy, Cryptogenic | 7.94e-05 | 82 | 255 | 6 | C0086237 | |
| Disease | Awakening Epilepsy | 7.94e-05 | 82 | 255 | 6 | C0751111 | |
| Disease | Aura | 7.94e-05 | 82 | 255 | 6 | C0236018 | |
| Disease | epilepsy (implicated_via_orthology) | 9.15e-05 | 163 | 255 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | body weight | RALGAPA1 NEXMIF MDGA2 BPTF TBC1D1 CDYL RMC1 MGA UNC79 NUP160 PLXNA1 DOCK1 RELCH COPG1 RBMS1 GRB10 POM121L2 PRDM4 RFX3 CRB1 NCOR1 EYS USF3 ASXL3 NPRL3 | 1.07e-04 | 1261 | 255 | 25 | EFO_0004338 |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.32e-04 | 12 | 255 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | microphthalmia (implicated_via_orthology) | 1.32e-04 | 12 | 255 | 3 | DOID:10629 (implicated_via_orthology) | |
| Disease | craniosynostosis (is_implicated_in) | 1.32e-04 | 12 | 255 | 3 | DOID:2340 (is_implicated_in) | |
| Disease | Intellectual Disability | RALGAPA1 STAG1 INPP4A KIF4A MEF2C BPTF KMT2C BRCA1 FGFR2 GRIN2B LRP2 MACF1 HTT | 1.54e-04 | 447 | 255 | 13 | C3714756 |
| Disease | Neurodevelopmental Disorders | 1.60e-04 | 93 | 255 | 6 | C1535926 | |
| Disease | Saethre-Chotzen Syndrome | 2.22e-04 | 3 | 255 | 2 | C0175699 | |
| Disease | Congenital hypoplasia of radius | 2.22e-04 | 3 | 255 | 2 | C0685381 | |
| Disease | Lacrimoauriculodentodigital syndrome | 2.22e-04 | 3 | 255 | 2 | C0265269 | |
| Disease | Levy-Hollister syndrome | 2.22e-04 | 3 | 255 | 2 | cv:C0265269 | |
| Disease | Bladder Neoplasm | 2.24e-04 | 140 | 255 | 7 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.34e-04 | 141 | 255 | 7 | C0005684 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 3.29e-04 | 16 | 255 | 3 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 3.29e-04 | 16 | 255 | 3 | cv:C1839071 | |
| Disease | T-Cell Lymphoma | 3.29e-04 | 16 | 255 | 3 | C0079772 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 3.29e-04 | 16 | 255 | 3 | 415000 | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 4.41e-04 | 4 | 255 | 2 | EFO_0801909 | |
| Disease | TWIST1-related craniosynostosis | 4.41e-04 | 4 | 255 | 2 | cv:C4551902 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 5.16e-04 | 43 | 255 | 4 | DOID:9261 (is_marker_for) | |
| Disease | Disproportionate short stature | 5.52e-04 | 77 | 255 | 5 | C0878659 | |
| Disease | intelligence, self reported educational attainment | 5.52e-04 | 117 | 255 | 6 | EFO_0004337, EFO_0004784 | |
| Disease | lymphocyte measurement | 5.52e-04 | 117 | 255 | 6 | EFO_0803546 | |
| Disease | high grade glioma (implicated_via_orthology) | 5.64e-04 | 44 | 255 | 4 | DOID:3070 (implicated_via_orthology) | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 6.14e-04 | 45 | 255 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | feeling miserable measurement | 6.21e-04 | 79 | 255 | 5 | EFO_0009598 | |
| Disease | bone disease (implicated_via_orthology) | 7.31e-04 | 5 | 255 | 2 | DOID:0080001 (implicated_via_orthology) | |
| Disease | Klatskin's tumor (is_implicated_in) | 7.31e-04 | 5 | 255 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | Macrothrombocytopenia | 7.31e-04 | 5 | 255 | 2 | C2751260 | |
| Disease | Autosomal Recessive Primary Microcephaly | 8.70e-04 | 22 | 255 | 3 | C3711387 | |
| Disease | Primary microcephaly | 8.70e-04 | 22 | 255 | 3 | C0431350 | |
| Disease | spermatogenic failure (is_implicated_in) | 9.94e-04 | 23 | 255 | 3 | DOID:0111910 (is_implicated_in) | |
| Disease | Malignant neoplasm of prostate | DCAF6 HAO1 ARID1A KMT2C CLPTM1L SERPINB10 BRCA1 MGA MSH3 CREBBP LEP NCOR1 LRP2 SPEN | 1.02e-03 | 616 | 255 | 14 | C0376358 |
| Disease | Prostatic Neoplasms | DCAF6 HAO1 ARID1A KMT2C CLPTM1L SERPINB10 BRCA1 MGA MSH3 CREBBP LEP NCOR1 LRP2 SPEN | 1.02e-03 | 616 | 255 | 14 | C0033578 |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 1.09e-03 | 6 | 255 | 2 | EFO_0801907 | |
| Disease | hypospadias (biomarker_via_orthology) | 1.09e-03 | 6 | 255 | 2 | DOID:10892 (biomarker_via_orthology) | |
| Disease | achondroplasia (implicated_via_orthology) | 1.09e-03 | 6 | 255 | 2 | DOID:4480 (implicated_via_orthology) | |
| Disease | Idiopathic Membranous Glomerulonephritis | 1.09e-03 | 6 | 255 | 2 | C0086445 | |
| Disease | Heymann Nephritis | 1.09e-03 | 6 | 255 | 2 | C1704378 | |
| Disease | Membranous glomerulonephritis | 1.09e-03 | 6 | 255 | 2 | C0017665 | |
| Disease | stomach carcinoma (is_marker_for) | 1.13e-03 | 24 | 255 | 3 | DOID:5517 (is_marker_for) | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.13e-03 | 24 | 255 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.13e-03 | 24 | 255 | 3 | C3805278 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.35e-03 | 139 | 255 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | blood rubidium measurement | 1.43e-03 | 26 | 255 | 3 | EFO_0021529 | |
| Disease | Cholangiocarcinoma | 1.43e-03 | 26 | 255 | 3 | C0206698 | |
| Disease | facial height measurement | 1.51e-03 | 142 | 255 | 6 | EFO_0007856 | |
| Disease | Craniosynostosis syndrome | 1.52e-03 | 7 | 255 | 2 | cv:C0010278 | |
| Disease | centronuclear myopathy (implicated_via_orthology) | 1.52e-03 | 7 | 255 | 2 | DOID:14717 (implicated_via_orthology) | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 1.52e-03 | 7 | 255 | 2 | EFO_0801906 | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 1.52e-03 | 7 | 255 | 2 | EFO_0020797 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 1.60e-03 | 27 | 255 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | Sezary Syndrome | 1.60e-03 | 27 | 255 | 3 | C0036920 | |
| Disease | Adenoid Cystic Carcinoma | 1.79e-03 | 100 | 255 | 5 | C0010606 | |
| Disease | primary pulmonary hypertension (is_marker_for) | 2.01e-03 | 8 | 255 | 2 | DOID:14557 (is_marker_for) | |
| Disease | NRF2 measurement | 2.01e-03 | 8 | 255 | 2 | EFO_0009794 | |
| Disease | glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement | 2.01e-03 | 8 | 255 | 2 | EFO_0800533 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.13e-03 | 152 | 255 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 2.18e-03 | 206 | 255 | 7 | C0152013 | |
| Disease | mitral valve prolapse (is_implicated_in) | 2.57e-03 | 9 | 255 | 2 | DOID:988 (is_implicated_in) | |
| Disease | RNA-binding protein 24 measurement | 2.57e-03 | 9 | 255 | 2 | EFO_0802030 | |
| Disease | microcephaly (implicated_via_orthology) | 2.63e-03 | 32 | 255 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | Prostate cancer, familial | 3.03e-03 | 69 | 255 | 4 | C2931456 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 3.20e-03 | 10 | 255 | 2 | EFO_0801535 | |
| Disease | OCIA domain-containing protein 1 measurement | 3.20e-03 | 10 | 255 | 2 | EFO_0008252 | |
| Disease | Endometrial Carcinoma | 3.54e-03 | 72 | 255 | 4 | C0476089 | |
| Disease | stomach cancer (is_implicated_in) | 3.54e-03 | 72 | 255 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | endometrial cancer (is_implicated_in) | 3.69e-03 | 36 | 255 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | smoking status measurement, forced expiratory volume | 3.89e-03 | 11 | 255 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | interleukin-6 measurement, response to stimulus | 3.89e-03 | 11 | 255 | 2 | EFO_0004810, GO_0050896 | |
| Disease | Congenital long QT syndrome | 3.89e-03 | 11 | 255 | 2 | cv:C1141890 | |
| Disease | lung adenocarcinoma | 4.15e-03 | 174 | 255 | 6 | EFO_0000571 | |
| Disease | Schizophrenia | SPTBN2 PCDH17 BRCA1 NUFIP2 FGFR2 GRIN3A GRB10 GRIK1 GRIN2B LEP TENM4 VPS35 LRP2 IL3RA GABBR1 PINK1 | 4.53e-03 | 883 | 255 | 16 | C0036341 |
| Disease | endometrial carcinoma (is_implicated_in) | 4.64e-03 | 12 | 255 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | ovarian reserve | 4.64e-03 | 12 | 255 | 2 | EFO_0004770 | |
| Disease | Long QT syndrome | 4.64e-03 | 12 | 255 | 2 | cv:C0023976 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 4.64e-03 | 12 | 255 | 2 | C0023485 | |
| Disease | household income | 5.16e-03 | 304 | 255 | 8 | EFO_0009695 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 5.34e-03 | 41 | 255 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 5.34e-03 | 41 | 255 | 3 | C0858252 | |
| Disease | rhinitis (biomarker_via_orthology) | 5.45e-03 | 13 | 255 | 2 | DOID:4483 (biomarker_via_orthology) | |
| Disease | phosphocreatine measurement | 5.45e-03 | 13 | 255 | 2 | EFO_0010521 | |
| Disease | upper aerodigestive tract neoplasm | 5.76e-03 | 246 | 255 | 7 | EFO_0004284 | |
| Disease | Alzheimer disease, educational attainment | 5.88e-03 | 247 | 255 | 7 | EFO_0011015, MONDO_0004975 | |
| Disease | Proteinuria | 6.10e-03 | 43 | 255 | 3 | C0033687 | |
| Disease | basal cell carcinoma | 6.18e-03 | 189 | 255 | 6 | EFO_0004193 | |
| Disease | unipolar depression, mood disorder | 6.27e-03 | 134 | 255 | 5 | EFO_0003761, EFO_0004247 | |
| Disease | Metabolic Bone Disorder | 6.32e-03 | 14 | 255 | 2 | C0005944 | |
| Disease | receptive language perception, parental genotype effect measurement | 6.32e-03 | 14 | 255 | 2 | EFO_0005686, EFO_0005939 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QRVESTVIPESTIMR | 71 | Q99996 | |
| ELNSVMTVRAQLAPS | 376 | P59826 | |
| SEPCTILQLDMRTVQ | 301 | P55345 | |
| NMEIINSTIETLAPD | 131 | Q9Y6F8 | |
| NMEIINSTIETLAPD | 131 | Q9Y6F7 | |
| MENLSLSIEDVQPRS | 206 | Q8IYS0 | |
| TTQSALPLTSEMLIA | 1361 | O94986 | |
| MTQNSSSLGDRIITP | 1 | Q5VVS0 | |
| LSIPSEVEMQCTLRN | 101 | Q8IW19 | |
| PSINSIVLSTQMATL | 141 | Q5SY80 | |
| SSINEEITPRRQSMT | 686 | P11274 | |
| SPSNEVNLLDSRTVM | 56 | P54756 | |
| AVTSINRNRTLMPNT | 61 | P39086 | |
| SRVTSDPQSNDIMLV | 106 | P49863 | |
| EIITTTVPEDIMSNR | 431 | O95870 | |
| NSERETEQTPALIMV | 631 | Q01954 | |
| SSVLAETLTQVSPQM | 236 | Q92793 | |
| LSEAEQATRTMQALP | 431 | P01024 | |
| SETRILLQGTPVAQM | 976 | P01024 | |
| ELPMFSQSELRTIEQ | 401 | A6QL63 | |
| RSAIELDTPSMTAEQ | 136 | Q9BTE6 | |
| PLSSNMIERSVVEAA | 56 | P56282 | |
| AQILNMEPLSDVTAT | 606 | Q53GS7 | |
| TALSAESTPMQVVTL | 871 | P20594 | |
| TASTMVTARPEQSQI | 281 | P17544 | |
| LMLEETRNTITVPAS | 811 | Q58WW2 | |
| PRLQTMTNVFVTSLA | 66 | P13945 | |
| TALSAESTPMQVVTL | 886 | P16066 | |
| SSADSTIMDIQVPTR | 31 | Q96DB9 | |
| QSTEDAMTVLTPLTE | 2916 | Q12830 | |
| SPQVLSRSTTMNERA | 46 | Q8TCP9 | |
| TPATARQQIAMSAIV | 1306 | O14578 | |
| MSVILLTPDELTNSS | 51 | Q8N608 | |
| MVTQSETLAVPREVA | 206 | Q5H9R4 | |
| ETSPISNSSINERMA | 751 | Q9C0F0 | |
| NSVMVSTTTEPRQRV | 591 | O94823 | |
| APQSLLTMEEIQSVE | 596 | P25098 | |
| TTVEPQEVTASMIRL | 96 | Q8TBY9 | |
| NVSEETVSPTRARNM | 46 | Q96SN8 | |
| LNSTTQSVLSRPMQR | 121 | Q5TC82 | |
| TMELFSNIVPRTAEN | 3081 | P49792 | |
| TRLTQAEISEQPTMA | 1131 | Q70E73 | |
| NLSTRDASILTEMPT | 446 | Q8TDF5 | |
| TNASETPATRMSIIQ | 841 | O14917 | |
| VAPGNQVTLRMTTDE | 121 | Q15113 | |
| SIATNRMITQTSITP | 276 | P29558 | |
| TTAGIQVLQEVSMSR | 621 | Q4ADV7 | |
| ASPTSTEEEQVMLRN | 486 | Q96PE3 | |
| MRRSSIQSTFSINPE | 231 | Q92542 | |
| TPDNASQEELMITLV | 571 | Q8IWA4 | |
| ISVSPLMNSLVSQVI | 2261 | O14497 | |
| TLELSNGSMVRITIP | 596 | Q9H1A4 | |
| AIMITNFELPRTQTD | 531 | Q4KMQ2 | |
| PTMSSIEEVNNRSLI | 1121 | Q6IE37 | |
| SLSPTNDLMVIAREQ | 81 | Q9H2M9 | |
| MSPLQDVSTIIGSRE | 791 | Q9P260 | |
| SSMNSNTPLVRITTR | 436 | P21802 | |
| STIMPRLSEEASQAL | 696 | P33991 | |
| LTLSPTSTLNMSQEE | 3076 | Q8WXI7 | |
| QELTLETMISPATSQ | 3761 | Q8WXI7 | |
| SQLDVTTLMSRIPQD | 5011 | Q8WXI7 | |
| ISPVVTSSSIRDNMV | 9546 | Q8WXI7 | |
| RSELETRMSSLQPVE | 411 | P20585 | |
| ATLTVMVIDTNDNRP | 2261 | Q96JQ0 | |
| TLSMPNNVTRESRAS | 611 | Q9H511 | |
| LQTMIRTSPNSLVTI | 306 | P10071 | |
| ESGMTQLQSLTVTVP | 1181 | Q8NEZ4 | |
| SVSRPLQMNETTANR | 1931 | Q8NEZ4 | |
| LSIVPSQTISSDLMN | 1666 | Q5T1H1 | |
| AAIQPDTSLVSVMTV | 191 | Q9Y697 | |
| LENTTAVTPMTAISD | 1606 | Q8IWI9 | |
| QRTQPESSSMLREQI | 36 | Q09328 | |
| RIAQPSMTASPQTEE | 536 | Q86YR5 | |
| SLQILPTTRVMSAEI | 51 | Q13201 | |
| EIVMLNPANTRSISN | 426 | Q9UBS5 | |
| RLAIQEMVSLTSPSA | 886 | O75335 | |
| VVPTSNVLTMLNDAL | 581 | Q658Y4 | |
| QVARMDTPQLTLTEL | 826 | Q9BY66 | |
| SLLTQASTLMSVQPE | 356 | Q9UPA5 | |
| QPSEVSSTEVNMRSR | 406 | Q6DN72 | |
| SSTEVNMRSRTLQEP | 411 | Q6DN72 | |
| LTVQPRNVSVTMSQV | 566 | Q9UIW2 | |
| EAILNTMSQELVPAS | 231 | Q9BXM7 | |
| TMSQELVPASRVALA | 236 | Q9BXM7 | |
| VRMTLRITENTPISS | 2551 | Q02505 | |
| PRNTTISLLTTDDAM | 46 | O76083 | |
| NLVMQSTGVLTATRE | 206 | P22794 | |
| MRDNTSPISVILVSS | 1 | Q12980 | |
| MATESPATRRVQVAE | 1 | Q01415 | |
| PRMLRNVAETDLSTS | 51 | Q9UJM8 | |
| AVIERVEMPTSASQA | 236 | Q63ZY6 | |
| LTSMPSRNVIQISND | 86 | P41159 | |
| VSQDPVSNMSITERL | 1786 | P50851 | |
| TMPSVSEDVDLLLNQ | 266 | Q06413 | |
| LMNLISQEETSTPTQ | 396 | Q9H223 | |
| PFQTINVERTVMSLD | 2411 | P98164 | |
| LTNRLQPSAMVDEAT | 636 | Q07864 | |
| SVFVLDTVRSNQMPS | 1511 | Q07864 | |
| VVPTQSTLTADDMRR | 491 | Q9NQV6 | |
| VTDNILAMARPSSEL | 86 | A2A3K4 | |
| SRRTSLVEPEMTSQA | 26 | Q86UU5 | |
| VEMIQDSTQRTADIP | 126 | Q9BSG0 | |
| DATLEIIVVMNSPSN | 71 | Q9ULW8 | |
| RESSLILAVTPANMD | 166 | P50570 | |
| RSSERMVITQTDPDV | 381 | Q7Z553 | |
| ISPELANMIQIDSSE | 2756 | Q9UPN3 | |
| MSELRVTLDPVQLES | 4931 | Q9UPN3 | |
| TSPVLNIMVIQTETD | 126 | Q7Z6M3 | |
| VARAVATATMIQPEL | 396 | Q8TCU5 | |
| QLGVTLSMTRTELSP | 276 | Q7Z3B4 | |
| IPMTFLITSTNRTNR | 166 | Q96P68 | |
| SSVTPNMLVNFLVER | 71 | Q8WZ92 | |
| NRTELMQASLDPSVT | 271 | P05187 | |
| RNNVTDPSLSEMVVV | 301 | P05186 | |
| PISSSISNMELELNI | 586 | P38398 | |
| EREMGNENIPSTVST | 1011 | P38398 | |
| RLMSSSVDTPQQLQS | 1471 | Q9Y2I7 | |
| LTEIQTSPETSMREV | 586 | O60353 | |
| MENGSITSIRSELIP | 216 | Q9NR50 | |
| VSTTAPMDSNLIQLT | 221 | P10398 | |
| ALSPTASDAVTQMIL | 836 | Q6YHK3 | |
| PSITDVTMENNLSRV | 991 | P42858 | |
| MQPVITEQVRDRTSF | 246 | P26951 | |
| SLESSLQVSLMSRQP | 536 | Q93033 | |
| QASDESQRMVLTVLP | 926 | Q93033 | |
| QTALTVMRPDASLQV | 941 | O75054 | |
| PVMQSDRTAIRSDTT | 326 | Q9P2N7 | |
| MSLLNSSEFQPQIRT | 281 | Q4AC94 | |
| AVPITRMQSSEDTEA | 2041 | Q4AC94 | |
| EISPLENAIETMQLT | 1486 | Q14185 | |
| TISPLENAIETMSTA | 1491 | Q92608 | |
| SSENNSLNPEVMREV | 361 | Q9Y232 | |
| SLNPEVMREVQSALS | 366 | Q9Y232 | |
| SQPMVDVSILQRSLA | 181 | Q96JJ3 | |
| PTIQASEMSNVVREL | 446 | Q5T197 | |
| SEMSNVVRELLETLP | 451 | Q5T197 | |
| IPEISIQDMTAQVTS | 2166 | P21333 | |
| DPTMIRANCLVQTTE | 191 | P29279 | |
| DVPDDISVRVMSSQS | 261 | Q4ZHG4 | |
| LTMQVSSLQREPFTI | 66 | P35659 | |
| TSPMEIVTQQDIVLS | 76 | Q6ZU35 | |
| NDPLLTVLTQDSMTV | 661 | P51795 | |
| TRLESIQQCMSQPDV | 271 | Q6PIV2 | |
| SQPMTEVDLFISTQR | 511 | Q02410 | |
| TLSSSLLQSVEEPMV | 141 | Q9H0A8 | |
| IQQVSSTPSTRMDVV | 86 | O14645 | |
| TTIQMSVEESTPISR | 291 | Q04637 | |
| TSIQVVLLSATMPTD | 206 | Q14240 | |
| LTTTESRQQPMALAV | 831 | P10253 | |
| IISILESMSNDTSLP | 256 | Q9NYL2 | |
| TTTPARVDLQQQIMT | 31 | Q5SQI0 | |
| SITVEPSENLQSLME | 376 | O95239 | |
| STPVRSVSENSLVAM | 421 | Q13322 | |
| DIVMTQSPDSLAVSL | 21 | P06312 | |
| TVNVMPSASRVILLE | 1251 | Q8IWT3 | |
| VQMIQDEESPLQSLS | 536 | Q5VZK9 | |
| TVTMQVTARSLEELP | 851 | Q9Y678 | |
| MTEAQLSTAVIENPE | 386 | P54198 | |
| ESNASMSSNTPLVRI | 426 | P22607 | |
| NNRPLVASMLVTVTD | 1236 | Q9NYQ7 | |
| EVTLSMTDPLSQTSR | 1036 | P82279 | |
| SREDMLAISTPVLTS | 366 | Q6UWW8 | |
| EELVLSEMNSPSRTQ | 646 | Q4V328 | |
| IMSATLRVEDFTQNP | 406 | Q8IY37 | |
| PAESNSISRITANME | 361 | Q9HCS5 | |
| ISSSNLNPREAMEAV | 151 | Q00888 | |
| ISSSNLNPREAMETV | 151 | Q9UQ72 | |
| VQDTLTPEVLLSAMR | 311 | Q96S37 | |
| LTETRNMPLVETIAA | 506 | A6NK97 | |
| SLATELTMLSARSPQ | 306 | A6NKX4 | |
| EQQSAREMTEVLPSQ | 326 | Q9UDX3 | |
| MSIFTPTNQIRLTNV | 1 | Q9Y3A5 | |
| LNQRSIMESPANSIE | 511 | P51170 | |
| IAIDTTQLNMSVTDP | 31 | Q8TC92 | |
| PRISISNVQLADTVM | 496 | O94829 | |
| LTQTPTEMQRVSLRF | 26 | Q9BUN1 | |
| QQSTTTMLPLVISEE | 471 | O43933 | |
| VPMRQAAVTSTSLTI | 181 | P20273 | |
| EMLTTNVPEIQRTNL | 911 | Q14562 | |
| PSIQRMVRLSSSDSI | 761 | Q15648 | |
| ISSSNLNPRETMEAV | 151 | P11464 | |
| TETAMTLPSESRVNI | 381 | Q9H9A6 | |
| STILQMPRASAEELA | 421 | Q8N309 | |
| AITMENVSRVTSPIS | 191 | Q9UKN5 | |
| PQELTMTQFLSIIRS | 61 | Q9BXW4 | |
| MVTSLSLPVQEDAQV | 351 | Q9UN75 | |
| PDSEIATTSLRVSLM | 331 | O75928 | |
| ENPRVLSFSLTSQTM | 866 | Q9Y6K5 | |
| MSTVRATLRSTENTP | 461 | Q9H195 | |
| SRPEQSVMQALESLT | 111 | Q504T8 | |
| SSITTAITQLLTQMP | 1136 | A6NKG5 | |
| VLTARPQSMENSPTI | 426 | Q9HCH5 | |
| LMLVSPQQTVTRAET | 126 | Q92750 | |
| EMVVPRSSNVLSEDQ | 206 | P21283 | |
| SASQLSPTELTEMRN | 31 | Q9NYK5 | |
| VPESMTISELRQATV | 461 | Q8TEQ0 | |
| QLMSTPVASSSRLER | 6 | Q6P5X7 | |
| LSMTDPSRAQTVDTE | 626 | Q8TF05 | |
| TVIDSSVMEQNPLRS | 251 | Q7Z6K3 | |
| RPEETMLSVSEQVSQ | 276 | Q5H9J9 | |
| VVPTSNVLTMLNDAL | 226 | P0C866 | |
| VSSMRAQTLEREVPS | 1761 | O14513 | |
| TTRASPATIEMAIET | 151 | P48380 | |
| SLSQPQMLIVSDIED | 561 | O95486 | |
| MAEVSREIAPTQSSE | 901 | Q5QGS0 | |
| ISSSNLNPREAMEAV | 151 | Q00887 | |
| SPSPSVRTQETMLQQ | 1756 | O75376 | |
| VRTQETMLQQRPSVF | 1761 | O75376 | |
| VMTSLQSILENVDTP | 276 | Q96Q15 | |
| RSQEHVEMLQEITPT | 3481 | Q96Q15 | |
| NSPFLTITSMTRVIE | 221 | P04843 | |
| TADMTNTAELLEQIP | 1141 | Q14524 | |
| MSLLSANTPEEDQRT | 221 | Q9H0W8 | |
| NALMTDETISNVPIL | 116 | Q9NR31 | |
| RSQRVSENTMLPFVS | 71 | Q9BXF9 | |
| FRVTSMQAVINETPL | 2046 | Q9UKZ4 | |
| ASESTLLAQEPREMT | 936 | Q9NSE4 | |
| ITIMEVQRESSPSLS | 131 | Q8N6D2 | |
| EEMPSLLTSTVQVAS | 211 | Q9HB58 | |
| MANRFVSSPQTIVEL | 811 | Q12769 | |
| ELNPTSRIAEAMLQT | 1061 | Q92954 | |
| SRIAEAMLQTTTRPN | 1066 | Q92954 | |
| MFTQVLSSVVQISPR | 701 | Q96KW2 | |
| TLTSPRMVAADNQDT | 2106 | Q8IWZ3 | |
| MVINRSTTELPLTVS | 226 | Q96KA5 | |
| ILMRFTVDQTQTPSL | 776 | O75122 | |
| TAPSMASVLEQLNVI | 1226 | O75153 | |
| NRDSVLIQTLAEMTP | 831 | Q14690 | |
| QPRAISIQSSEMIAT | 596 | A0JNW5 | |
| PTTRLVTIMLANNET | 186 | Q96I15 | |
| LRSMIEVLNTDSSPR | 841 | Q8NBP0 | |
| LMSSPQSRTVRSENL | 906 | Q5W0Q7 | |
| TIMVLVVQRTDSIPN | 56 | P32971 | |
| IQASTMIISRVPNIS | 741 | Q7Z392 | |
| ELQLAPSMTTVDQLE | 931 | Q7Z392 | |
| NMDNDLEVLTSSPTR | 541 | Q9Y5T5 | |
| TLVSCIQIRSEENMP | 1566 | Q6GYQ0 | |
| IVLTAASVQSMPDTE | 116 | Q13009 | |
| VISRMPVSIDLENSQ | 2621 | Q96T58 | |
| MLLSTAQVDLPSQTD | 481 | Q7Z417 | |
| GEQLLQVTMTTTSPA | 491 | Q96EK2 | |
| TLEPEMNTLAAQITA | 896 | O15020 | |
| PTSNSSATIARELLM | 456 | Q9NUL3 | |
| PQNLVTDRVTENMAT | 711 | Q9UQP3 | |
| QMLSESDRASLPVIA | 396 | Q96DM3 | |
| LQLMSTEITEISTPS | 276 | Q9HAI6 | |
| QVATVIQSRQDMPSE | 331 | Q96QK1 | |
| IQSRQDMPSEDVVSL | 336 | Q96QK1 | |
| MDQPAVATASTSIRE | 1 | Q8N801 | |
| TSSLPVVMISNVSQL | 446 | Q14765 | |
| MATASSQVLIPEINL | 341 | O15344 | |
| QPTDIEENRTMLFTI | 281 | Q86TI0 | |
| EDPTSRQRAMSIASI | 696 | Q99250 | |
| PSENRVSALTQMESA | 136 | Q9Y3B3 | |
| PMPRQISRQSSVTES | 36 | Q6ZUI0 | |
| DRLSSVTMPNVARQT | 1951 | Q6N022 | |
| VTMPNVARQTLETIR | 1956 | Q6N022 | |
| RSMNDISLTPNTDQR | 276 | Q9BY07 | |
| MITSELPVLQDSTNE | 1 | Q8WVM7 | |
| ASMLPETTREDVTSN | 1101 | Q68DE3 | |
| LEQQMVSQPSIVTRS | 1636 | Q68DE3 | |
| LMNPFRLENVTVSES | 81 | B3SHH9 | |
| TARMNLTQILEPSTV | 1181 | Q2KHR2 | |
| RLPMNQIVTSVTIAA | 391 | O15405 | |
| PSIMVSASIDQRLTF | 1056 | Q9NNW5 | |
| QVIITREDMSTFIQP | 126 | Q3KNS6 | |
| MRTQISLSTDEELPE | 26 | P42681 | |
| LITTSELMLERSPQV | 511 | Q6ZMS4 | |
| TPTRSLTAQLQETMT | 221 | P59923 | |
| LSLVVNVMQRDSIPS | 1211 | Q9UPU5 | |
| DLTTSEMEQLRISPA | 1521 | Q9UPU5 | |
| PSSDGMNVTTRLIQE | 926 | Q9UL36 | |
| PTSQRVQSVEIDMFS | 956 | Q9UI33 | |
| EETQQRMSTVLAPSQ | 366 | A2RU30 | |
| RMSTVLAPSQTLDSN | 371 | A2RU30 | |
| ISSSNLNPREAMETV | 151 | P11465 | |
| MVNNVTPARAVVSLI | 1366 | Q9Y4F4 | |
| PAALSIMAQSTSIQR | 506 | Q5T4S7 | |
| PDDSVDSTTRMILVN | 171 | P48595 | |
| DSPEVNITDVRMTSP | 266 | P51854 | |
| RLEESSPNILNNSMS | 1586 | Q96QT4 | |
| NIPSVTTDMLTRLSD | 761 | Q9P1Q0 | |
| ENTPTESLARLVAMV | 516 | Q9P2D8 | |
| STTMLQVTSLSPINE | 26 | Q8N402 | |
| LQERPSTESMQAVIL | 76 | Q15048 | |
| LTAVDPETNMNVSEI | 26 | P38571 | |
| SDMNPSIQSALILET | 666 | Q86UW6 | |
| PNDTSEMLEVVANTR | 1806 | Q6PIF6 | |
| AIEERQSVMNSPTAT | 876 | Q13224 | |
| TPDILLSRVNQITMS | 1766 | P20929 |